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Tissue engineering, involving the use of three-dimensional (3-D) scaffolds for cell 
and tissue culture, is a promising technique for establishing in vitro culture models that 
mimic in vivo environments. In vitro models present ethical and cost advantages over in 
vivo models, and allow for controlled, mechanistic studies on factors that regulate normal 
and abnormal tissue development. Alginate, a linear polysaccharide derived from brown 
algae, has properties that make it a favorable material as a 3-D extracellular matrix for in 
vitro cell and tissue models. After demonstrating alginate’s tunable physical and chemical 
properties with respect to gel formation, stiffness, and cellular interactions, alginate 
hydrogel was employed in two separate culture systems that share in common the 
ultimate goal of serving as in vitro models of tissue development and function: 1) an in 
vitro model of pig embryo elongation to develop strategies for improving pregnancy 
outcomes, and 2) an in vitro model of growth plate cartilage to discover factors necessary 
for inducing native cartilage architecture for tissue engineering applications. In regards to 
pig embryo culture, embryos encapsulated within alginate hydrogels exhibited greater 
survival and morphological changes than non-encapsulated control embryos, along with 
increased expression of steroidogenic transcripts and estrogen production, consistent with 
	  
in vivo elongation. For the growth plate model, alginate hydrogels were used for the 
encapsulation of mouse growth plate chondrocytes in vitro to study the effects of soluble 
parathyroid hormone (PTH), a signaling factor that regulates growth plate structure and 
function in vivo, along with the effects of an arginine-glycine-aspartic acid (RGD) 
peptide conjugated to the alginate. PTH and RGD peptide treatment resulted in decreased 
collagen X and Indian hedgehog transcript expression in encapsulated chondrocytes, 
demonstrating the role of these factors on the regulation of chondrocyte hypertrophy in 
vitro. Overall, information gained from utilizing these in vitro models as research tools 
can be used to advance the field of developmental biology and enhance tissue 
engineering therapies for the treatment of degenerative diseases. 
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CHAPTER 1 
Thesis Introduction and Background 
1.1. Introduction 
The tissue engineering approach to cell and tissue culture, involving the use of 
three-dimensional (3-D) scaffolds, is a promising technique for establishing in vitro 
culture models that mimic in vivo environments. Alginate, a linear polysaccharide 
derived from brown algae, has properties that make it a favorable material as a 3-D 
extracellular matrix (ECM) for in vitro cell or tissue models. Alginate forms a hydrogel 
by ionic-crosslinking in the presence of a divalent cation, allowing for gentle 
encapsulation of cells or tissue. In addition, alginate hydrogel can be chemically modified 
to promote specific interactions between cells or tissue and the surrounding hydrogel, or 
can be left unmodified to solely provide mechanical support for tissue morphogenesis 
and/or cellular responses. For this thesis, alginate hydrogel was used to develop two 
separate culture systems that share in common the ultimate goal of serving as in vitro 
models for tissue development and function. For the first project, alginate hydrogel was 
investigated as a 3-D matrix for the in vitro development of pre-implantation pig 
embryos. Between day 10 and 12 of gestation in the pig, embryos undergo a dramatic 
morphological change, known as elongation. Deficiencies in elongation contribute to 
approximately 20% of embryonic loss, but exact mechanisms of elongation are poorly 
understood. In order to provide an in vitro tool for evaluating mechanisms of elongation, 
the first objective of this thesis was to utilize alginate hydrogels as 3-D scaffolds for the 
encapsulation and support of porcine embryo elongation in vitro. Secondly, alginate 
hydrogel was investigated as a 3-D matrix for the establishment of an in vitro growth 
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plate model. Physical damage or congenital disorders that disrupt growth plate cartilage 
result in skeletal abnormalities that are often associated with long-term intensive 
healthcare needs due to impact on the joints, central nervous system, and ocular system. 
Studying the generation of growth plate architecture in vitro is critical for understanding 
mechanisms that regulate normal development of growth plate cartilage and how these 
mechanisms are altered in abnormal growth plates, in addition to enhancing tissue 
engineering strategies. Therefore, the second objective of this thesis was to determine the 
extracellular factors required to induce native growth plate structure and function within 
3-D alginate hydrogels. Overall, in addition to advancing the field of developmental 
biology, the physiological information gained from using these in vitro models as 
research tools can be used to enhance fertility and pregnancy outcomes as well as tissue 
engineering and cell-based therapies for the treatment of degenerative diseases. 
 
1.2. Tissue Engineering 
	  
The use of autologous or allogeneic grafts in traditional transplantation surgeries 
has serious limitations, including a lack of available donor tissues and severe immune 
responses, respectively [1]. Tissue engineering is a relatively new field that combines 
engineering with the life sciences in order to develop functional tissue substitutes, and 
has the potential to revolutionize medicine by providing optimal replacement tissues for 
those damaged due to injury or disease [2]. Advantages of tissue engineering include the 
use of autologous or allogeneic cells to overcome the limitation of donor tissue 
availability, as well as the ability to directly control in vitro culture conditions to model 
those that occur in vivo [3]. The basic principle of tissue engineering involves three main 
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components [4]. First, living cells are needed in order to produce the desired tissue. The 
cells are often derived from donor tissue or from stem or progenitor cells [2, 4]. 
Secondly, a 3-D scaffold is needed to provide structural support for the growing tissue 
and maintenance of cell-to-cell communication. These scaffolds often mimic the in vivo 
environment of the tissue by setting appropriate mechanical properties and chemical 
signals. Tissue engineering scaffolds can be made of synthetic materials, such as the 
polyglycolic or polylactic family of polymers, or they can be made of natural materials, 
such as collagen, alginate, or chitosan [2-5]. The final essential component of tissue 
engineering is the inclusion of bioactive signals, as they are used to establish cell-scaffold 
interactions and provide the necessary chemical stimuli to promote cell growth and 
differentiation [2-4]. Taken together, these three components of tissue engineering can 
act synergistically to develop functional tissue substitutes for the replacement of diseased 
or damaged tissue.   
 
1.3. Alginate 
1.3.1. Structure and properties 
Hydrogels, i.e. networks of hydrophilic polymer chains with high water content, 
are highly appealing as 3-D scaffolds for in vitro cell and tissue culture due to their 
ability to mimic the physical properties of native soft tissue [6], as well as their high 
porosity for efficient diffusion of proteins and nutrients [7]. Alginate hydrogel, in 
particular, is widely used in tissue engineering applications due to its desirable properties 
as a biomaterial [8]. Alginate is a linear polysaccharide produced as an ECM component 
in brown algae and some bacteria. The polysaccharide is composed of repeating units of 
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β-D-mannuronic acid (M) and α-L-guluronic acid (G) [9] (Fig. 1-1) and forms a hydrogel 
by ionic cross-linking of the G residues in the presence of a divalent cation (Fig. 1-2) 
[10].  
 
Calcium chloride (CaCl2) solution is commonly used as the crosslinking reagent 
for alginate and provides an external gelation method for creating alginate beads. 
Alginate solution can be dropped into CaCl2, immediately forming a 3-D network of 
highly hydrated gel [11]. Sodium chloride (NaCl) is often added to the CaCl2 solution for 
greater uniformity and higher porosity of the resulting alginate gel by providing anti-
gelling cations; if NaCl is not added, the alginate at the surface of the bead becomes 
tightly packed, limiting further diffusion of the calcium ions into the center of the gel [7]. 
Hindered diffusion leads to an alginate bead with higher mechanical stiffness at the 
108 K.Y. Lee, D.J. Mooney / Progress in Polymer Science 37 (2012) 106– 126
Fig. 1. Chemical structures of G-block, M-block, and alternating block in alginate.
the length of each block, and more than 200 different algi-
nates are currently being manufactured [14]. The G-block
content of L. hyperborean stems is 60%, and for other com-
mercially available alginates is in the range of 14.0–31.0%
[10].
Only the G-blocks of alginate are believed to participate
in intermolecular cross-linking with divalent cations (e.g.,
Ca2+) to form hydrogels. The composition (i.e., M/G  ratio),
sequence, G-block length, and molecular weight are thus
critical factors affecting the physical properties of alginate
and its resultant hydrogels [15]; the mechanism of gela-
tion will be addressed in more detail in a later section.
The mechanical properties of alginate gels typically are
enhanced by increasing the length of G-block and molec-
ular weight. It is important to note that different alginate
sources provide polymers with a range of chemical struc-
tures (e.g., bacterial alginate produced from Azotobacter
has a high concentration of G-blocks and its gels have a
relatively high stiffness [16]). The physical properties sig-
nificantly control the stability of the gels, the rate of drug
release from gels, and the phenotype and function of cells
encapsulated in alginate gels.
2.2. Molecular weight and solubility
The molecular weights of commercially available
sodium alginates range between 32,000 and 400,000 g/mol.
The parameters of the Mark–Houwink relationship
([!] = KMva) for sodium alginate in 0.1 M NaCl solution at
25 ◦C are K = 2 × 10−3 and a = 0.97, where [!] is intrinsic
viscosity (mL/g) and Mv is the viscosity-average molecu-
lar weight (g/mol) [17]. The viscosity of alginate solutions
increase as pH decreases, and reach a maximum around
pH 3–3.5, as carboxylate groups in the alginate backbone
become protonated and form hydrogen bonds.
Increasing the molecular weight of alginate can improve
the physical properties of resultant gels. However, an algi-
nate solution formed from high molecular weight polymer
becomes greatly viscous, which is often undesirable in pro-
cessing [18]. For example, proteins or cells mixed with an
alginate solution of high viscosity risk damage from the
high shear forces generated during mixing and injection
into the body [19]. Manipulation of the molecular weight
and its distribution can independently control the pre-
gel solution viscosity and post-gelling stiffness. The elastic
modulus of gels can be increased significantly, while the
viscosity of the solution minimally raises, by using a combi-
nation of high and low molecular weight alginate polymers
[20].
2.3. Biocompatibility
Although the biocompatibility of alginate has been
extensiv ly evaluated in vitro as well as in vivo, there is
still debate regarding the impact of the alginate compo-
sition. Much of this confusion, though, likely relates to
varying levels of purity in the alginate studied in various
reports. For example, it has been reported that high M con-
tent alginates were immunogenic and approximately 10
times more potent in inducing cytokine production com-
pared with high G alginates [21], but others found little
or no immunoresponse around alginate implants [22]. The
immunogenic response at the injection or implantation
sites might be attributed to impurities remaining in the
alginate. Since alginate is obtained from natural sources,
various impurities such as heavy metals, endotoxins, pro-
teins, and polyphenolic compounds could potentially be
present. Importantly, alginate purified by a multi-step
extraction procedure to a very high purity did not induce
any significant foreign body reaction when implanted
Fig. 1-1. Chemical structures of G-block, M-block, and alternating 
block in alginate (Reprinted from Lee and Mooney, Progress in 
Poly er Science, 2012). 
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surface and lower stiffness in the center. In addition, radial channels develop in the gel 
when the alginate is crosslinked in CaCl2 solution without the addition of NaCl [12]. 
Alginate hydrogels can also be formed using internal gelation methods, in which a 
calcium slurry, usually calcium carbonate (CaCO3) or calcium sulfate (CaSO4), is mixed 
into the alginate solution and gelation occurs as the calcium slowly leaks from within the 
alginate [11]. In this case, release of the calcium is caused by a reduction in pH that may 
be harmful to cells that are within the alginate solution during gelation. However, the 
internal gelation method may be useful for seeding cells on pre-formed alginate scaffolds 
[11].  
 
The external gelation process, which commonly involves CaCl2, allows for gentle 
encapsulation of cells and tissue without negatively affecting cell viability. The alginate 
gel forms a mesh-like structure, with pore sizes ranging from 5 to 200 nm, that permits 
diffusion of proteins and hormones essential for cell and tissue growth and development 
[7, 13]. Increasing the concentration of alginate in the gels decreases the rate of diffusion 
of proteins through the pores [13]. Gels made of alginate with a high G content have the 
most open pore structure and therefore allow for the greatest rate of protein diffusion [7]. 
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Fig. 4. Alginate hydrogels prepared by ionic cross-linking (egg-box model) [38]. Only guluronate blocks participate in the formation of a corrugated
egg-box-like structure with interstices in which calcium ions are placed. Copyright 2007, Elsevier Science Ltd., Oxford, UK.
biological reactions, along with more general limitations of
ionically cross-linked gels has led to interest in covalently
cross-linked alginate hydrogels.
3.1.2. Covalent cross-linking
Covalent cross-linking has been widely i vestigated in
an effort to improve the physical properties of gels for
many applications, including tissue engineering. The stress
applied to an ionically cross-linked alginate gel relaxes as
the cross-links dissociate and reform elsewhere, and water
is lost from the gel, leading to plastic deformation. While
water migration also occurs in covalently cross-linked gels,
leading to stress relaxation, the inability to dissociate and
reform bonds leads to significant elastic defor ation [45].
However, covalent cross-linking reagents may  be toxic, and
the unreacted chemicals may  need to be removed thor-
oughly from gels.
Covalent cross-linking of alginate with poly(ethylene
glycol)-diamines of various molecular weights was  first
investigated in order to prepare gels with a wide range
of the mechanical properties. While the elastic modulus
initially increased gradually with an increase in the cross-
linking density or weight fraction of poly(ethylene glycol)
(PEG) in the gel, it subsequently decreased when the molec-
ular weight between cross-links (Mc) became less than
the molecular weight of the softer PEG [46]. It was sub-
sequently demonstrated that the mechanical properties
and swelling of alginate hydrogels can be tightly regulated
by using different kinds of cross-linking molecules, and
by controlling the cross-linking densities. The chemistry
of the cross-linking molecules also significantly influences
hydrogel swelling, as would be expected. The introduc-
tion of hydrophilic cross-linking molecules as a second
macromolecule (e.g. PEG) can compensate for the loss of
hydrophilic character of the hydrogel resulting from the
cross-linking reaction [47].
The use of multi-functional cross-linking molecules
to form hydrogels provides a wider range and tighter
control over degradation rates and mechanical stiffness
than bi-functional cross-linking molecules. For exam-
ple, the physical properties and degradation behavior of
poly(aldehyde guluronate) (PAG) gels prepared with either
poly(acrylamide-co-hydrazide) (PAH) as a multi-functional
cross-linker or adipic acid dihydrazide (AAD) as a bi-
functional cross-linker were monitored in vitro. PAG/PAH
gels showed higher mechanical stiffness before degrada-
tion and degraded more slowly than PAG/AAD gels. The
enhanced mechanical stiffness and prolonged degradation
behavior could be attributed to the multiple attachment
points of PAH in the gel even at the same concentration of
overall functional groups [48].
Photo cross-linking is an exciting approach to in situ
gelation that exploits covalent cross-linking. Photo cross-
linking can be carried out in mild reaction conditions,
even in direct contact with drugs and cells, with the
appropriate chemical initiators. Alginate, modified with
me hacr late and cross-linked by exposure to a laser ( rgon
ion laser, 514 nm)  for 30 s in the presence of eosin and tri-
ethanol amine, forms clear and flexible hydrogels. The gels
were useful for sealing corneal perforation in vivo, indi-
cating a potential clinical use in sutureless surgery [49].
Photo cross-linking reactions typically involve the use of
a light sensitizer or the release of acid, which may be
harmful to the body. An alternative photo cross-linking
approach uses polyallylamine partially m dified with !-
phenoxycinnamyldiene acetylchloride, which dimerizes
on light exposure at about 330 nm,  and releases no toxic
byproducts during the cross-linking reaction [50]. The
mechanical properties of the gels formed from this pho-
tosensitiv  poly llylamin  and alginate were significantly
improved by light irradiation, and the gels were freely per-
meable to cytochrome c and myoglobin [51].
3.1.3. Thermal gelation
Thermo-sensitive hydrogels have been widely investi-
gated to date in many drug delivery applications, due to
their adjustable swelling properties in response to temper-
ature changes, leading to on-demand modulation of drug
release from the gels [52]. Poly(N-isopropylacrylamide)
(PNIPAAm) hydrogels are the most extensively exploited
thermo-sensitive gels, and these undergo a reversible
phase transition near body temperature in aqueous media
(lower critical solution temperature near 32 ◦C). The
transition temperature can be altered by copolymeriza-
tion with hydrophilic monomers such as acrylic acid
and acrylamide [53]. Despite the potential importance
of thermo-sensitive hydrogels in biomedical applica-
tions, few systems using alginate have been reported
yet, as alginate is not inherently thermo-sensitive. How-
ever, semi-interpenetrating polymer network (semi-IPN)
structures were prepared via in situ copolymerization
of N-isopropylacrylamide (NIPAAm) with poly(ethylene
glycol)-co-poly("-caprolactone) (PEG-co-PCL) macromer
in the presence of sodium alginate by UV irradiation (Fig. 5).
The swelling ratio of the gels increased with the concen-
tration of sodium alginate at a constant temperature, and
Fig. 1-2. Alginate hydrogels prepared by ionic cross-linking (egg-
box model). Only guluronate blocks participate in the formation of a 
corrugated egg-box-like structure with interstices in which calcium 
i s are placed (Reprinted from Lee and M oney, Progress in 
Polymer Science, 2012). 
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In addition to its gentle encapsulation process and diffusion capabilities, alginate 
promotes negligible non-specific protein adsorption and cell adhesion, leading to minimal 
interaction between encapsulated cells/tissue and the surrounding alginate hydrogel [14]. 
This feature allows alginate to act as a “blank slate”. If left unmodified, alginate gels can 
be used to solely provide mechanical support to cells or tissues; varying the concentration 
of alginate alters the mechanical properties of the resulting matrix and can be used to 
evaluate the effect of matrix mechanics on cell or tissue growth [15]. Otherwise, specific 
extracellular factors can be added to the alginate to control the interaction between 
encapsulated cells/tissue and the surrounding alginate hydrogel.  
Degradation of alginate hydrogels does not readily occur in physiological 
conditions [16, 17], although some de-crosslinking can occur due to the gradual diffusion 
of calcium ions out of the matrix [18]. Increased degradation occurs in the presence of a 
chelating agent, such as ethylenediaminetetraacetic acid (EDTA), lactate, citrate, or 
phosphate, which increases the removal of calcium ions from the matrix [13]. No known 
alginate-degrading enzymes exist in humans, but alginate lyases have been isolated from 
marine algae and a wide range of microorganisms [11]. Alginate lyases cause degradation 
of alginate via a β-elimination mechanism, in which the glycosidic 1  4 O-linkage 
between monomers is cleaved [19]. The lack of degradation in physiological conditions 
by alginate hydrogels makes alginate an appropriate material for maintaining structural 
integrity during relatively long culture times when used for in vitro cell or tissue culture. 
Alginate lyase or a chelating agent such as EDTA can then be used to easily retrieve the 
cells or tissue from the alginate bead if necessary for further assays. Due to these unique 
physical and chemical properties of alginate, along with its innate biocompatibility, 
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alginate has been employed in biomedical and food industries, as described below, 
including its recent popularity as a matrix for tissue engineering applications. 
 
1.3.2 Applications 
Alginate is commonly used in the food industry as a thickening agent to increase 
the quality of foods, such as ice cream and dressings, demonstrating its biocompatibility 
and low toxicity [11]. It has also been widely used in the pharmaceutical industry as a 
drug or protein delivery agent; alginate gels can release macromolecules in a controlled 
manner and can be orally administered or injected in a non-invasive approach [20]. 
Examples of alginate research for pharmaceutical applications include studies on 
composite alginate/poly(lactic-co-glycolic) microparticles for insulin delivery [21], 
coated chitosan-alginate beads for oral delivery of the antibiotic drug cefaclor [22],  and 
tamoxifin-loaded nanoparticles for the treatment of breast cancer [23]. Recently, alginate 
research has shifted to tissue engineering applications due to its biocompatibility, 
relatively low cost, and gentle gelation process [11, 20]. Specifically, alginate hydrogels 
are favorable for cell transplantation or immobilization and can be used to deliver cells to 
a desired site in vivo or provide a controlled 3-D environment for new tissue formation in 
vitro [20]. Alginate gels have previously been used for the encapsulation and culture of a 
variety of cell types, including articular chondrocytes [24, 25], skeletal myoblasts [26, 
27], neural stem cells [28], and mouse embryonic stem cells [29]. 
In addition to cell encapsulation, alginate hydrogels have demonstrated success as 
a 3-D extracellular matrix for the in vitro culture of organs and embryos, for the purpose 
of developmental studies [30], disease simulation [31], and advancing in vitro 
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fertilization techniques [32]. In regards to organ culture, alginate hydrogels have 
previously been used to support in vitro development of ovarian follicles in mice [15, 32, 
33] and nonhuman primates [34], cryopreserved-thawed human cortical follicles [35], 
and sections of ovaries and oviducts to model specific changes that might lead to ovarian 
cancer [36]. The studies involving mouse ovarian follicle culture have demonstrated that 
encapsulation of follicles within alginate hydrogels enhances follicle maturation in vitro 
and can lead to subsequent fertilization in vitro [37]. For embryo culture, alginate 
hydrogels have previously been successful for the in vitro development of mouse 
pronuclear stage embryos [30] and bovine embryos up to the blastocyst stage [38]. The 
results of these previous studies provide evidence that alginate has great potential as an 
artificial 3-D extracellular matrix that can support in vitro culture of cells, tissues, and 
organs, making it the scaffold of interest for the in vitro models established in this thesis. 
However, despite the intrinsic properties of alginate that make it a favorable material for 
tissue engineering applications, chemical modifications are often required to promote 
desirable cellular functions, provide a greater range of mechanical properties, and/or 
provide controlled release of encapsulated factors.  
 
1.3.3. Chemical modifications 
Alginate’s free hydroxyl and carboxyl groups along its molecule chain provide 
numerous sites that are ideal for chemical functionalization. Properties such as 
degradability, hydrophobicity, and biological characteristics can be altered by 
functionalizing available hydroxyl and/or carboxyl groups, or interfering with carbon-
carbon bonds [39]. For example, to decrease alginate gel stiffness and increase 
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degradability in physiological conditions, oxidation of alginate is often employed, which 
lowers the molecular weight (MW) of the polysaccharide [15, 39]. Sodium periodate, 
which is used for the oxidation reactions, breaks carbon-carbon bonds of the guluronate 
group yielding an adduct that does not form ionic bridges with divalent cations [40]; 
therefore, less crosslinking occurs, leading to lower mechanical stiffness of the resulting 
gel. Furthermore, partial oxidation of alginate creates acetal groups that are susceptible to 
hydrolysis. Consequently, increasing the degree of oxidation increases degradability of 
the resulting alginate gel in physiological conditions [41]. 
Another useful chemical modification of alginate is sulfation, prepared through 
the reaction of alginate with chlorosulfuric acid in formamide [39]. This process gives 
alginate a structural similarity to heparin and therefore promotes high blood 
compatibility. Sulfation of alginate also mimics heparin’s high affinity for certain growth 
factors; therefore, alginate-sulfate hydrogels have been used to provide protection and 
sustained release of heparin-binding growth factors, such as basic fibroblast growth 
factor, which is valuable for in vivo delivery systems and tissue engineering applications 
[42].  
A common modification of alginate, especially for cell encapsulation purposes, is 
amidation, in which carbodiimide chemistry is used to form amide linkages between 
amine-containing molecules and the carboxylic acid functional groups of the alginate 
polymer backbone [39]. This type of chemistry is useful for covalently linking specific 
peptides to the alginate backbone to promote cell-matrix interactions, as cell adhesion is 
often a strict requirement for cell viability and proliferation [14]. The arginine-glycine-
aspartic acid (RGD) peptide sequence, which is found in extracellular matrix proteins 
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such as fibronectin and laminin, is the most effective and commonly used peptide 
sequence to promote cell adhesion [43]. When covalently linked to alginate, RGD peptide 
sites serve as ligands to cell integrins to mediate cell migration and adhesion, and the 
ligand density can be varied to produce a desired degree of adhesion [14]. Overall, the 
tunable physical and chemical characteristics of alginate make it an ideal candidate as a 
3-D matrix for tissue engineering strategies, including those used for the establishment of 
in vitro models of tissue development and function, as described below. 
 
1.4. In vitro models of development 
While traditional tissue engineering studies have focused on using scaffolds for 
tissue regeneration for transplantation therapies, as described earlier, the field of tissue 
engineering, in particular the use of scaffolds, is now being explored for other 
applications, such as studies on drug efficacy and toxicology as well as investigations on 
tissue development and morphogenesis. For these applications, an in vitro tissue model 
presents ethical and cost advantages over in vivo models, and allows for mechanistic 
studies on simple, controlled systems [44]. Traditional two-dimensional (2-D) culture 
systems result in a disruption of cell-to-cell interactions as cells attach to the substrate 
and migrate away from the tissue [33, 45]. Consequently, cells and tissue often behave 
very differently when cultured in two dimensions and experience major differences in 
gene expression due to the lack of a natural 3-D environment [46]. Three-dimensional 
culture systems can maintain embryo or tissue architecture and allow for direct physical 
interaction with the surrounding environment, which better mimics in vivo development. 
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Therefore, the tissue engineering approach provides an exciting, more physiologically 
natural alternative to traditional 2-D systems as in vitro models of development. 
The use of tissue engineering principles to establish in vitro models that closely 
resemble in vivo conditions provides a means for researchers to evaluate normal and 
abnormal embryo or tissue development, as well as factors that affect development. 
Understanding native embryo and tissue development is important for advancing the field 
of developmental biology, which focuses on uncovering mechanisms involved in cell 
growth, differentiation, and morphogenesis. Knowledge of developmental biology 
mechanisms, specifically those involving gene regulation of cell differentiation and tissue 
specification, can be integrated with other biological fields to help solve major questions 
that still exist in those areas [47].  
Examples of in vitro culture systems that have employed the tissue engineering 
approach include models for ovarian follicle [32-34] and embryo development [48-51], as 
well as in vitro organ models such as kidney [31], cardiac [52], skin [53], and oviduct 
models [36]. Human skin models, in particular, have served as in vitro test systems for 
pharmaceutical research [53], and cardiac tissue models have provided a means for 
electrophysiological studies of the heart [52], a complicated task to evaluate by in vivo 
measures. In addition, in vitro tumor models have recently become highly appealing for 
studying the efficiency of chemotherapy drugs [54], as well as factors involved in tumor 
initiation and progression [55]. The physiological and pathophysiological information 
gained from using these in vitro models as research tools can be used for enhancing 
fertility and pregnancy outcomes as well as tissue engineering and cell-based therapies 
for the treatment of degenerative diseases. The research presented in this thesis 
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specifically focuses on the establishment of two separate in vitro models of development 
using alginate hydrogel as the 3-D matrix: a model for the development of pre-
implantation pig embryos and an in vitro growth plate model. The context and impact of 
these two culture models are presented in the following sections.  
 
1.5. Pre-implantation pig embryo development 
1.5.1. Developmental hallmarks 
	  
In the pig, the pre-implantation period of pregnancy is characterized by several 
developmental hallmarks that have significant impacts on embryo survival, uterine 
capacity, and subsequent pre-weaning survivability. Between day 10 and 12 of gestation, 
the embryo is transformed from a spherical structure (~1-2 mm) to a long thin, filament 
(>100 mm) in a process referred to as elongation [56]. During elongation, the embryo 
produces and secretes estrogen, which serves as the key molecule for maternal 
recognition of pregnancy and also modulates the production and secretion of proteins and 
growth factors within the uterus [56]. Elongation of the pig embryo is also characterized 
by significant changes in gene regulation as the embryo undergoes this transition [57, 
58]. In conjunction with the increase of estrogen production and secretion by the embryo 
during elongation, several transcripts involved in steroidogenesis, such as steroidogenic 
acute regulatory protein [59], cytochrome P450 side chain cleavage (CYP11A1), and 
aromatase (CYP19A1), are increased in a similar pattern as estrogen production during 
embryo elongation [58, 60]. Unlike elongation in other domestic animals, rapid 
elongation of the pig embryo has been primarily associated with cellular remodeling and 
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differentiation rather than cellular hyperplasia [61]. As a result, potential markers for 
differentiation of the trophectoderm (i.e., cytokeratin-18 [KRT18]) and mesoderm (i.e., 
vimentin [VIM]) have been identified in the elongating pig blastocyst [62-64].  
Proper interactions between the embryo and receptive uterine endometrium are 
essential for supporting embryonic development and subsequent implantation [65]. These 
interactions are initiated by the immune responsive cytokine, interleukin-1β (IL1B), 
which is produced by the embryo and uterine endometrium during elongation and may be 
responsible for suppressing the maternal immune response to prevent rejection of the 
embryo [66]. The increase in IL1B expression during trophoblastic elongation, and its 
association with the initiation of estrogen production by the embryo, suggests that IL1B 
may have a critical role in pre-implantation embryo development [67]. 
Many uterine specific factors have been shown to be up-regulated within the 
uterine milieu as the embryo initiates elongation and subsequently transitions to its 
superficial implantation on the uterine endometrium [68]. For instance, fibroblast growth 
factor 7 (FGF7), transforming growth factor-betas (TGFBs), osteopontin (OPN), 
fibronectin (FN), and laminin (LN) have been suggested to play a role in embryo-
maternal interactions during elongation and implantation [69, 70]. OPN, in particular, is 
an ECM glycoprotein secreted by uterine epithelial cells that plays a role in the porcine 
implantation cascade during pregnancy [71]. Previous evidence has suggested that the 
RGD peptide of OPN binds to integrins alpha 5 and beta 3 on the embryonic 
trophectoderm, inducing cytoplasmic reorganization during embryo elongation by 
stimulating cell-cell adhesion and promoting cell migration [71]. OPN has been shown to 
enhance development of early porcine embryos to the blastocyst stage in vitro when 
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added exogenously to culture media [72]. The surface of the oviduct and uterus contains 
several other ECM components that have been found to influence embryonic 
development, morphogenesis, and function by stimulating cell-cell interactions [73, 74]. 
Two ECM glycoproteins involved in cellular adhesion, FN and LN, have previously been 
shown to increase the hatching rates of cultured human embryos when added to the 
culture media [75]. A study involving the culture of porcine blastomeres on FN-coated 
culture dishes demonstrated that FN enhanced development to the blastocyst stage 
compared to control treatment groups [76], suggesting its role in early embryonic 
development. Given the potential involvement of these growth factors and ECM 
components during early embryonic development in the pig, further investigations are 
warranted to elicit the exact mechanisms of pig embryo elongation. The alginate culture 
model established in this thesis for pre-implantation pig embryo development can serve 
as the necessary tool for studying the affects of these factors on embryo development and 
elongation in a controlled, in vitro environment. In addition to advancing knowledge in 
reproductive biology, the mechanisms uncovered with our in vitro culture model can be 
used to address critical issues with embryonic loss, as described below. 
 
1.5.2. Embryonic loss in the pig 
In the pig, 30-50% of ova released from the ovary do not result in a piglet, despite 
a typically high fertilization rate (>95%) [77, 78]. Therefore, low pregnancy rates are 
primarily the result of early embryonic or fetal loss.  Approximately 20 percent of 
embryonic loss occurs during the pre-implantation period of pregnancy in the pig, with a 
significant proportion of these losses occurring due to deficiencies in embryo elongation 
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[77]. Furthermore, adequate embryo elongation is necessary for successful implantation 
and ultimately affects embryo spacing, placental development, and fetal growth, which 
have implications on uterine capacity, litter size, and even postnatal piglet health [79]. 
Better understanding of factors that regulate elongation is needed in order to assess 
mechanisms contributing to embryonic loss. Knowledge of these mechanisms can then be 
used to develop strategies (e.g. marker-assisted selection, nutrient or hormone 
supplements that may improve reproductive efficiencies by decreasing embryo losses in 
early gestation) to improve pregnancy outcomes in the pig and potentially other domestic 
agricultural species. Therefore, an in vitro model that can facilitate embryo elongation is 
essential for evaluating factors that promote or impede elongation. However, past efforts 
to establish such models have not been met with success. 
 
1.5.3. Previous studies on in vitro elongation of embryos 
Previous attempts to culture embryos at later stages, incorporating a type of 
supporting structure, have been largely unsuccessful. In cattle, limited elongation of 
embryos in vitro was demonstrated using an agar gel tube system [48, 49, 80]; however, 
embryos cultured in this system had deficiencies in the development of the embryonic 
disk [49, 81]. This agar system did not provide for complete encapsulation and support of 
the embryos. Instead, the tubes merely served as reservoirs for growth, and the embryos 
grew to fill these tubes via physical induction. Thus, the shape of the tube may have 
forced growth that appeared as elongation, and the high percentages of agar used may 
have restricted optimal embryonic development. Furthermore, high levels of media 
supplements may have resulted in rapid cell growth, further contributing to the 
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appearance of embryonic elongation. Nevertheless, attempts to replicate these results 
using pig embryos have been unsuccessful [81]. 
Moreover, a previous study that investigated morphological changes of in vivo-
produced bovine embryos within the agar gel tube system reported that only 3% of the in 
vivo-produced embryos initiated morphological changes following in vitro culture [82]. 
These findings highlight the dramatic environmental change that in vivo-produced 
embryos experience when transitioning from the uterine environment to an in vitro 
environment. Therefore, more efficient in vitro embryo culture systems are needed that 
can ease the embryo’s transition from the uterine environment and facilitate 
morphological changes that are consistent with in vivo elongation. The in vitro alginate 
culture system developed for this thesis (described in Chapter 3) addresses this critical 
need by serving as a model that can facilitate embryo morphological changes and other 
corresponding hallmarks of elongation. This alginate culture system was then translated 
to serve as an in vitro matrix for the establishment of a growth plate model in the second 
part of this thesis, the context of which is described in the following sections.  
 
1.6. Architecture and development of growth plate cartilage 
1.6.1. Zonal arrangement of chondrocytes 
Longitudinal growth of long bones occurs at the ends of the epiphyseal plate, also 
known as the growth plate, which is a distinct cartilage region located at each end of a 
long bone [83]. The complex development of the growth plate, involving an array of 
signaling pathways for controlled patterning and growth of long bones, can serve as a 
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template for natural tissue regeneration, which has become a major focus of tissue 
engineering studies [84]. Within growth plate cartilage, chondrocytes differentiate in a 
spatially regulated manner that results in morphologically and functionally distinct zones 
of cells, forming a continuum from the long bone’s epiphysis towards the diaphysis (Fig. 
1-3) [83, 85]. At the epiphyseal end, small, round progenitor cells make up the resting 
zone. These relatively quiescent cells enter into the cell cycle and begin to differentiate 
into rapidly proliferating, flattened chondrocytes that organize into columns as they 
divide, making up the proliferative zone of about 10-20 cells per column [83, 84]. The 
chondrocytes of the resting and proliferating zones secrete structural proteins, 
predominately type II collagen, forming a hyaline cartilage matrix [83, 85]. Continuing 
towards the diaphysis, the chondrocytes stop dividing and begin to differentiate further 
into prehypertrophic cells, adopting a more spherical morphology [84]. The 
prehypertrophic chondrocytes terminally differentiate into hypertrophic chondrocytes that 
swell, i.e. hypertrophy, increasing their volume about 5-10 fold during the process [84]. 
This increase in size is a principal contributor of longitudinal bone growth and therefore 
bone lengthening is primarily driven by the production of hypertrophic chondrocytes 
from the proliferating columns [83, 84]. Chondrocytes in the hypertrophic zone primarily 
synthesize type X collagen and remodel the cartilage matrix into a calcifying matrix [84, 
85]. At terminal differentiation, chondrocytes induce blood vessel invasion through the 
secretion of specific proteins such as vascular endothelial growth factor (VEGF) and 
attract bone-forming osteoblasts [83, 85]. Finally, hypertrophic chondrocytes undergo 
apoptotic cell death and osteoblasts invade the mineralized cartilage matrix, leading to 
the initiation of bone formation [83, 85]. One distinction between engineered and native 
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cartilage is that engineered cartilage lacks the proper zonal arrangement of cells and 
extracellular matrix despite having normal gene expression profiles, suggesting that 
certain factors for inducing normal tissue architecture are yet to be determined. Several 
signaling pathways, which are described below, have been discovered to play a role in 
regulating growth plate architecture and function; however an in vitro growth plate model 
is warranted in order to determine additional factors that are required to induce normal 
growth plate structure and function.  
 
1.6.2. Signaling pathways and transcription factors that regulate growth plate function 
The orderly progression of cell proliferation and differentiation in growth plate 
cartilage is regulated by a complex network of opposing signaling pathways.  
Chondrocyte proliferation in the growth plate is partly regulated by a feedback loop 
involving the interactions of Indian hedgehog (Ihh), a member of the hedgehog family of 
Fig. 1-3. Functional zonal arrangement of the growth plate within long bones. 
	   19 
secreted ligands, and parathyroid hormone-related protein (PTHrP) [83-85] (Fig. 1-4). 
Prehypertrophic chondrocytes exiting the proliferative columns express Ihh, which 
stimulates the production of PTHrP by resting cells and perichondral cells, i.e. 
chondrocytes located at the bone ends near the articular surface [83, 85]. Ihh diffusion to 
the perichondral cells is regulated by heparin sulfate proteoglycans (HSPGs) in the 
extracellular matrix [86]. The PTHrP binds to its parathyroid hormone/PTHrP receptor 
expressed by proliferating chondrocytes and suppresses chondrocyte hypertrophy, 
retaining the chondrocytes in the proliferative zone [83, 85]. As chondrocytes in the 
proliferative columns become too distant from the PTHrP-producing cells located at the 
bone ends, PTHrP concentration becomes too low to stimulate them; this lack of 
stimulation causes the chondrocytes to stop proliferating, enter the pre-hypertrophic 
phase, and begin to synthesize Ihh [84]. This feedback loop therefore regulates the length 
of the proliferative columns in growth plate cartilage, defining individual zones of 
chondrocyte maturation. 
 
Fig. 1-4. Schematic illustration of the Ihh/PTHrP feedback loop. 
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Other signaling pathways that regulate endochondral development of bones 
include bone morphogenic proteins (BMPs), transforming growth factors, Wnts, and 
Fibroblast growth factors. These pathways, in addition to the Ihh-PTHrP signal pathway, 
influence growth plate function partially via the regulation of key transcription factors, 
most notably Sox9 and Runx2 [83, 85]. Sox9 acts at every stage of chondrocyte 
differentiation in the growth plate. It is expressed in mesenchymal cell condensations and 
is essential for converting them into chondrocytes [83, 84]. Sox9 is also expressed in 
proliferating chondrocytes but not in hypertrophic chondrocytes, and is necessary for 
restricting chondrocyte differentiation, preventing cells from converting to hypertrophic 
chondrocytes prematurely [83]. Furthermore, Sox9 is critical for stimulating the 
expression of many ECM components, including Collagens type II, IX, XI and aggrecan 
[84, 87]. Runx2, on the other hand, is necessary for driving proliferative chondrocytes to 
differentiate further into hypertrophic chondrocytes [83]. In addition, Runx2 promotes the 
differentiation of mesenchymal progenitor cells into osteoblasts [84]. It is expressed in all 
osteoblasts as well as in hypertrophic chondrocytes [84]. 
Although significant advances have been made in discovering signal pathways 
and signaling gradients that regulate growth plate function, it is unclear whether these 
factors alone are sufficient to induce normal growth plate structure and function because 
current methods for in vitro culture of naïve chondrocytes do not generate native cartilage 
architecture. An in vitro model of the growth plate can therefore serve as the necessary 
tool for evaluating these factors. Defining the microenvironmental parameters that 
generate cartilage architecture is a crucial step toward the development of systems to 
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regenerate native cartilage, with the ultimate goal of addressing critical health issues that 
are described in the following section.  
 
1.6.3. Cartilage injury and disease 
Physical damage or genetic disorders that disrupt normal growth plate function 
can result in skeletal abnormalities. Osteochondrodysplasias, a group of disorders 
characterized by abnormal growth and remodeling of bone and cartilage, affect between 
1/3000 to 1/5000 individuals and occur with over 200 different phenotypes [88]. 
Mutations responsible for these dysplasias may cause defects in the synthesis of 
extracellular matrix proteins, specific growth factors, receptors, and transcription factors 
[89].  These dysplasias often result in disorders of decreased or increased bone density 
leading to proportionate short stature in the case of osteodysplasias, or disproportionate 
short stature with short trunk or short limbs in the case of chondrodysplasias [88]. In 
addition to affecting quality of life, short stature and craniofacial defects are often 
associated with long-term intensive health care needs as a result of impact on the joints, 
the central nervous system, and the ocular system [90, 91]. Therefore, along with 
advancing the field of developmental biology, studying the generation of growth plate 
architecture in vitro is critical for enhancing tissue engineering strategies to provide 
optimal replacement tissue for abnormal or damaged growth plates. While an in vitro 
growth plate model has the potential to serve as a tool for these studies, proper zonal 
arrangement of chondrocytes, in particular the proliferating columnar zone, has not yet 
been established by previous efforts, which are described in detail below. 
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1.6.4. Previous studies on engineering growth plate cartilage 
Previous attempts to establish an in vitro growth plate model have failed to induce 
native growth plate architecture, in particular a distinct zone of proliferating columnar 
chondrocytes. A study involving the encapsulation of porcine growth plate chondrocytes 
in 1.25% alginate beads demonstrated that expression patterns of hormone receptors and 
matrix proteins in chondrocytes cultured in alginate beads were more similar to that of 
native growth plates than chondrocytes grown in 2-D monolayers [92]; however, there 
was no report of proliferating chondrocytes forming columns within the alginate gels. 
Another study involving the encapsulation of proliferating chondrocytes from fetal 
bovine chondrocytes demonstrated that a 102-mM calcium chloride (CaCl2) cross-linking 
solution, without the addition of sodium chloride, caused radial channels to form within 
the alginate beads, and that proliferating chondrocytes became aligned within these 
channels [12]. Although this alignment appeared to mimic the columnar arrangement of 
proliferating chondrocytes in vivo, no further characterization of the chondrocytes other 
than electron microscopy was performed. The chondrocytes may have simply been filling 
these channels due to physical restriction; no evidence was reported of the encapsulated 
chondrocytes maintaining the appropriate genotype of native proliferating chondrocytes 
of the growth plate. More recently, a study was conducted to differentiate human bone 
marrow-derived mesenchymal stem cells (hBMSCs) within layered agarose constructs in 
order to promote zonal arrangement of chondrocytes [93]. Zonal cartilage did develop to 
an extent in this study due to the mechanical gradient of the scaffold, with small collagen 
type II negative proliferative cells at the base of the constructs and hypertrophic 
chondrocytes towards the surface. However, although proliferation was detected, a 
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distinct zone of proliferating columnar chondrocytes was not observed [93]. Therefore, a 
need still exists to establish a 3-D in vitro growth plate model that exhibits normal growth 
plate structure and function in order to elucidate mechanisms that regulate formation of 
proliferative chondrocyte columns, which in turn can be used to enhance tissue 
engineering strategies. The alginate hydrogel system established for this thesis involving 
the 3-D encapsulation of growth plate chondrocytes has the potential to address this need. 
 
1.7. Objectives of thesis 
The overall objectives of this thesis are to employ alginate hydrogels as a 3-D 
matrix to establish in vitro models of development and then evaluate factors that regulate 
growth and development in these systems. Specifically, this thesis focuses on two 
developmental models: 1) an in vitro culture system that can support porcine embryo 
elongation, and 2) an in vitro model of growth plate cartilage. These in vitro models can 
be used as tools for studying mechanisms of development and identifying factors that 
regulate or enhance tissue growth and function. Chapter 2 will detail hydrogel design and 
characterization that was explored for these projects. Chapter 3 will describe studies 
focused on porcine embryo development within alginate gels and Chapter 4 will focus on 
the preliminary studies involving the growth plate model. Finally, Chapter 5 will 
conclude the findings of this thesis and describe plans for future investigations. 
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CHAPTER 2 
Alginate gel design and characterization 
2.1. Introduction  
As described in Chapter 1, the fundamental elements of tissue engineering include 
cells, bioactive signals, and a 3-D scaffold to simulate the natural cellular environment by 
maintaining cell/tissue architecture and providing stimuli for growth and differentiation 
[4, 5]. The in vitro culture models established in this research project predominantly 
capitalize on the scaffold element of the tissue engineering approach to cell and tissue 
culture. Scaffold design is dependent on several factors, including physical properties 
(e.g. shape and mechanical integrity), mass transport properties (e.g. protein diffusion 
rate), and biological properties (e.g. cell adhesiveness), which greatly affect the success 
of tissue organization and development [1, 5]. Biomaterials that can be easily tuned to 
address these properties are ideal for tissue engineering applications so that optimal 
properties can be obtained for the desired outcomes. Hydrogels, i.e. networks of 
hydrophilic polymer chains with high water content, are a class of biomaterials that are 
widely used as tissue engineering scaffolds due to their ability to mimic the properties of 
native soft tissue [6], as well as their high porosity for efficient diffusion of proteins and 
nutrients [7]. Synthetic hydrogels such as polyethylene glycol [94] and natural hydrogels 
such as chitosan [95] and alginate [14] can be modified both physically and/or chemically 
to promote mechanical and biological cues, making them favorable as scaffolds for in 
vitro cell and tissue growth. This chapter will specifically focus on the design and 
characterization of alginate hydrogels as scaffolds for tissue engineering applications, in 
particular for use as in vitro culture models. 
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The principal purpose of a tissue engineering scaffold is to provide a framework 
in which tissue growth can occur by filling a space otherwise occupied by a native tissue 
or environment [5]. Physical properties that are essential to the success of the scaffold 
include gel formation characteristics and mechanical properties. As gel formation can 
dictate the direction in which tissue growth proceeds and how cell/tissue architecture is 
maintained, the first objective of this study was to investigate several methods for 
creating alginate gels of different forms, specifically focusing on designs that involve the 
external method of gelation (i.e. the use of calcium chloride [CaCl2] as the crosslinking 
agent). Mechanical properties of the gel should also be considered when exploring the 
optimal scaffold design for a specific application. The alginate gel must have enough 
structural integrity to withstand manipulation and maintain 3-D architecture of the 
encapsulated tissue for adequate cell-to-cell communication [5]; however, the gel must 
also be lenient enough to guide, not inhibit, cell and tissue growth. In addition, when cell 
integrins are coupled to the ECM, mechanical forces can be transduced into biochemical 
signals that influence cell behavior and function within the scaffold, a phenomenon 
known as mechanotransduction [96, 97]. Therefore, the stiffness of the artificial in vitro 
ECM (i.e., the scaffold) with which the cells are in contact can be an important regulator 
of basic cellular processes of proliferation, differentiation, and remodeling [96]. Stiffness 
was evaluated in the present study by determining Young’s modulus as a function of 
alginate concentration. 
In addition to physical properties, bioactivity is another design variable to 
consider when establishing a tissue engineering scaffold, as the scaffold must promote 
desired cellular functions and therefore proper tissue development [1, 5]. For example, 
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biomaterials can be modified to present specific ligands for cell adhesion, which can 
influence cell-matrix interactions and can lead to altered gene expression and cellular 
behavior [1]. Due to their very hydrophilic nature, many hydrogels, including alginate, do 
not readily promote protein adsorption or cell adhesion unless chemically modified [5, 
14]. The amino acid sequence arginine-glycine-aspartic acid (RGD), derived from 
numerous ECM proteins such as fibronectin, laminin, and collagen, is the most effective 
and commonly used peptide sequence for hydrogel modification to promote cell adhesion 
[5, 43]. Therefore, covalent attachment of an RGD peptide to the alginate polymer 
backbone and subsequent characterization of the conjugation were investigated in this 
study.  
Overall, the objective of these studies was to demonstrate alginate’s ability to be 
modified with respect to physical properties (i.e., gel formation and stiffness) as well as 
bioactivity (i.e. cell adhesiveness). Each of these gel design variables can then be used to 
investigate its influence on porcine embryo development and growth plate development 
with the in vitro culture models established and described later in this thesis.  
 
2.2. Methods 
2.2.1. Gel formation  
This section details several methods that were developed for creating alginate gels 
of different morphologies. The crosslinking solution used for each of these methods was 
prepared by dissolving calcium chloride (CaCl2; Sigma Aldrich, St. Louis, MO) and 
sodium chloride (NaCl; Sigma Aldrich) in sterile MilliQ water to obtain a 50 mM 
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CaCl2/140 mM NaCl solution. Alginate solutions were prepared by dissolving 
lyophilized alginate powder (Pronova UP MVG, >60% guluronic acid, 200,000 – 
300,000 g/mol; NovaMatrix, Sandvika, Norway) in sterile MilliQ water. The gel 
formation methods described below were tested with alginate concentrations ranging 
from 0.375% to 1.5% alginate (w/v).  
 
Alginate beads: 
A simple “drop” method, based on methods described by other investigators [33, 
98], was developed through our studies for the encapsulation of cells and tissues within 
alginate hydrogel beads (Fig. 2-1A) [50]. To create alginate beads on a scale large 
enough for the in vitro pig embryo model described in Chapter 3, 25-µL drops of alginate 
solution were slowly released from the edge of a wide-orifice pipette tip and gently 
touched to the surface of crosslinking solution (50 mM CaCl2/140 mM NaCl) to pull the 
droplet off the tip and into the solution. After 3 minutes of crosslinking time to ensure 
complete gelation, the beads were removed from the crosslinking solution and diameters 
were measured using a caliper. For cell encapsulation, this method was modified to 
produce smaller beads using 10-µL drops of alginate for the in vitro growth plate model 
investigated in this project. The “drop” method was then extended to allow for the 
addition of multiple layers of alginate gel around the first bead to ensure complete 
encapsulation of pig embryos, which was utilized in the studies described in Chapter 3 
(Fig. 2-1B). This double encapsulation method was also developed for future 
mechanical/chemical gradient or co-culture studies. To demonstrate the addition of a 
second layer, the 25-µL beads prepared during the first encapsulation were placed 
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individually into 45-µL drops of alginate. These drops containing the beads were then 
pipetted into crosslinking solution (50 mM CaCl2/140 mM NaCl) using a wide-orifice 
pipet tip, and were allowed to gel for an additional 3 minutes, resulting in double-layered 
alginate beads. The double-layered bead was observed with a Leica DMI 3000B inverted 
microscope (Leica Microsystems GmbH, Wetzlar, Germany) at 5x magnification.	  
 
  
Cylindrical alginate gels: 
An alginate hydrogel with a cylindrical morphology could provide extended space 
for tissue growth, while still maintaining a small enough radius for adequate diffusion of 
nutrients to the cells or tissue located within the gel. To create cylindrical alginate 
Fig. 2-1. Schematic illustration of the formation of alginate hydrogel beads, in conjunction 
with the encapsulation of embryos. A) Single encapsulation, resulting in an embryo 
encapsulated within one layer of alginate hydrogel. B) Double encapsulation, resulting in an 
embryo encapsulated within two layers of alginate hydrogel.  
Alginate droplet!
Embryo!
Embryos in media! Crosslinking 
solution!
Embryo 
encapsulated in 
alginate bead!
Embryo in 
alginate droplet!
Alginate droplet! Crosslinking 
solution!
Two-layered alginate 
bead with embryo 
encapsulated within!
Encapsulated 
embryo in alginate 
droplet!
Encapsulated 
embryo in single 
alginate layer!
A 
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hydrogels, a custom mesh mold was developed, consisting of a polypropylene mesh piece 
(0.021” x 0.027” opening size; McMaster Carr, Elmhurst, IL) held together with stainless 
steel syringe connectors (McMaster Carr) on each end (Fig. 2-2A). Approximately 500 
µL of alginate solution was pipetted directly into the cylindrical mold via the opened slit 
at the top of the mesh. The mold was then lowered into crosslinking solution (50 mM 
CaCl2/140mM NaCl) for 10 minutes to allow for complete gelation. After 10 minutes, the 
mold was removed from the crosslinking solution, the syringe connectors were taken off 
the ends of the mesh, and the resulting gel was gently peeled from the mesh using 
forceps. The diameter of the resulting gel was measured with a caliper. To create a 
cylindrical hydrogel for gradient and/or co-culture studies, alginate solutions of various 
concentrations (0.375% to 1.5%; dyed with food coloring) were consecutively added to 
the mesh mold (Fig. 2-2B) to demonstrate the formation of a mechanical gradient gel. 
 
Alginate gel tubes: 
A different approach to maintaining tissue architecture is to provide a reservoir 
for growth, in contrast to directly encapsulating the tissue within the hydrogel. Therefore, 
a method for creating a tubular alginate hydrogel was investigated and developed for this 
approach. Briefly, a glass microdispenser tube (Drummond, Broomall, PA) with a 1.5-
Fig. 2-2. A) Mesh mold used for creating cylindrical gels. B) Example of a gradient gel pre-
crosslinking; each dye color represents a different concentration of alginate solution.  
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mm outer diameter was added through the center of the mesh mold that was described 
above for creating cylindrical gels (Fig. 2-3). Alginate solution was then pipetted into the 
mesh mold, filling the space around the glass tube. After placing this mesh system into 
crosslinking solution for 10 minutes, the metal syringe connectors were removed from 
the ends of the mesh and the glass tube was slowly drawn out from the center of the gel. 
Finally, the resulting gel was carefully peeled from the mesh using forceps.  
 
Alginate wells: 
In addition to the hollow gel tube method described above, another method of 
creating a reservoir for tissue growth was developed, involving the creation of wells 
within alginate hydrogels. To create the wells, a long, narrow mesh mold was 
constructed, with an opened top in which to pipette the alginate solution. Alginate 
solution was then pipetted into the mesh mold until full, followed by the insertion of a gel 
electrophoresis comb into the alginate solution. This system was then placed into a basin 
of crosslinking solution (50 mM CaCl2/140 mM NaCl) (Fig. 2-4) for 1 hour to ensure 
stability of the resulting gel. After being removed from the crosslinking solution, the 
Fig. 2-3. Mold for creating alginate gel tubes, consisting of 
a cylindrical mesh frame with glass tube through the 
center. 
	   31 
comb was carefully removed from the alginate, and the resulting gel was peeled from the 
mesh mold.  
 
2.2.2. Chemical modification of alginate 
The RGD amino acid sequence is the most effective and commonly used peptide 
sequence for hydrogel modification to promote cell adhesion [5, 43]. To create bioactive 
alginate hydrogels, alginate was covalently modified with a glycine-arginine-glycine-
aspartic acid-serine-proline (GRGDSP) peptide (Anaspec, Fremont, CA) to a 
concentration of 4 µmol/g alginate using carbodiimide chemistry, as previously described 
[14]. Briefly, two grams of sodium alginate (NovaMatrix) were added to 200 mL of MES 
buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was allowed to dissolve for 7-8 
hours on a stir plate. 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC; Sigma Aldrich) 
was added to activate 5% of the uronic acids of the alginate polymer backbone in order to 
form amide linkages with the peptide. To stabilize the reactive EDC intermediate against 
a competing hydrolysis reaction, N-hydroxy-sulfosuccinimide (sulfo-NHS; Pierce, 
Fig. 2-4. The setup for the formation of alginate wells. A) Mesh system containing 
alginate, with gel electrophoresis comb inserted. B) Close-up of comb inserted into 
mesh mold.  
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Rockford, IL) was also added to the solution at a 2:1 EDC to NHS ratio. Lastly, the 
GRGDSP peptide was incorporated into the solution, conjugating to the alginate 
backbone via the terminal amine of the peptide. After 20 hours of reacting, the 
conjugation reaction was quenched through the addition of hydroxylamine hydrochloride 
(Sigma Aldrich). The alginate solution was then dialyzed against decreasing salt solutions 
and finally ddH2O over the course of 3 days. The final dialyzed solution was lyophilized 
to dryness and stored at -80°C until use. 
 
2.2.3. Confirmation of peptide conjugation 
Because unmodified alginate does not readily promote cell adhesion, a cell 
adhesion experiment was performed with unmodified alginate gels compared to 
GRGDSP-conjugated alginate (RGD-alginate) gels as an indirect method of confirming 
successful conjugation of the peptide. Briefly, 200 µL of 1% alginate or RGD-alginate 
solution was pipetted into wells of a 48-well plate. Next, 20 µL of 100 mM calcium 
chloride (CaCl2) solution was pipetted into the center of each well of alginate or RGD-
alginate solution. After 20 minutes of crosslinking, the gels were removed from each well 
and placed into a corresponding well of rinse media (Dulbecco’s Modified Eagle’s 
Medium [DMEM]; Gibco/Invitrogen, Carlsbad, CA) to remove excess calcium. After the 
rinse step, each gel was transferred to the bottom of a well of a 96-well plate immediately 
prior to cell seeding.  
Mouse bone marrow mesenchymal stem cells (D1 ORL UVA; ATCC, Manassas, 
VA) were cultured in T-75 flasks in DMEM supplemented with 10% fetal bovine serum 
(Invitrogen) and 1% penicillin/streptomycin (Invitrogen). For seeding, cells were counted 
	   33 
using a hemocytometer and trypan blue staining for viable cells after being dissociated 
with 0.05% trypsin-EDTA. Cells were then seeded onto each gel (n=3 gels per alginate 
condition) at a density of 20,000 cells/cm2 in 150 uL of cell culture media and cultured 
for 3 days at 37 ºC and 5% CO2. Gels were imaged 24 and 72 hours post-seeding to 
observe cellular adhesion using a Leica DMI 3000B inverted microscope (Leica 
Microsystems). Three images were taken per gel at 10x magnification and representative 
images are reported. Cells were then stained at 72 hours with 2 µM calcein AM/4 µM 
ethidium homodimer-1 and imaged with fluorescence microscopy to evaluate live and 
dead cells, respectively. 
To further verify successful conjugation of the GRGDSP peptide to the alginate 
polymer backbone, NMR spectroscopy was used to characterize the samples. Unmodified 
alginate and GRGDSP-alginate were dissolved in deuterium oxide (D2O; Sigma Aldrich) 
and placed in separate NMR tubes. The 1H-NMR spectra of the samples were recorded 
on a Bruker DRX-500 500 MHz NMR spectrometer at an operating frequency of 500.13 
MHz.  
 
2.2.4. Determination of Young’s modulus 
Sodium alginate (NovaMatrix) was dissolved in sterile MilliQ water to final 
concentrations of 0.375%, 0.5%, 0.7%, 1.0%, and 1.5% (w/v).  For each concentration, 
alginate solution was pipetted into cylindrical mesh molds (3.5 mm diameter), as 
described above in section 2.2.1 for cylindrical alginate gels, and the molds were placed 
into crosslinking solution (50 mM calcium chloride/140 mM NaCl) for 10 minutes to 
allow for complete gelation of the alginate. Following removal from the mesh molds, the 
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gels were cut into 5-mm pieces for mechanical testing. Exact height and diameter of the 
cylindrical gels were measured with a caliper and recorded for use in analysis. Young’s 
modulus values of the alginate gels were determined using a TMS-Pro texture analyzer 
(Food Technology Corporation, Sterling, VA). Samples were compressed 1 mm at a rate 
of 1 mm/min while force and displacement were recorded over time. Average Young’s 
modulus values were determined from the linear regions of the stress-strain curves, at 
strain values ≥ 0.1. These methods were then repeated with 0.5%, 1.0%, and 1.5% RGD-
alginate gels to any determine any effects of peptide conjugation on Young’s modulus of 
the resulting gels.  
 
2.2.5. Statistical Analysis 
All values are reported as mean ± standard error of the mean (SEM). For Young’s 
modulus studies, one-way analysis of variance (ANOVA) was used to determine if the 
mean Young’s modulus values between the different alginate concentrations were 
statistically different. Tukey’s multiple comparison test was then used to perform 
pairwise comparisons. Student’s t-test was used to compare the Young’s moduli of the 
alginate gels with those of the RGD-alginate gels to determine any significant differences 
between the two groups. Linear regression analyses were used to describe the relationship 
between alginate concentration and Young’s modulus. For these analyses, the r2 value 
(coefficient of determination) is reported, giving a measure of the reliability of the linear 
relationship.  
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2.3. Results 
2.3.1. Gel morphologies 
A method involving 25-µL alginate drops was developed to produce gels of an 
appropriate size for the in vitro pig embryo model. The 25-µL drops resulted in beads of 
approximately 3 mm in diameter, which is suitable for 0.5-1.0 mm embryos or tissue 
samples (Fig. 2-5A). For cell encapsulation for the growth plate model, the method was 
adjusted to make smaller beads, using 10-µL alginate drops. The 10-µL drops resulted in 
beads with a diameter of approximately 2.5 mm (Fig. 2-5A). A method for adding 
multiple gel layers was then investigated for pig embryo studies, as well as future studies 
involving gradients and co-cultures. Encapsulating the first bead within a second drop of 
alginate resulted in a double-layered alginate gel, with a second layer gel thickness 
ranging from ~200-400-µm around the first bead (Fig. 2-5B).  
 
The method developed for creating cylindrical alginate hydrogels, employing a 
custom mesh mold, resulted in 3-cm long gel with a diameter of approximately 3.5 mm 
(Fig. 2-6A). However, the length of the gel can easily be varied with this mold by 
Fig. 2-5. Representative images of alginate beads. A) Alginate beads made from a 25-µL 
alginate drop (left) and 10-µL alginate drop (right), B) Representative 5x bright field image of 
a double-layered alginate bead: ‘1’ denotes the inner bead and ‘2’ denotes the second alginate 
layer (scale bar = 200 µm). 
25-uL 10-uL 
1 
2 
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utilizing mesh pieces of a greater length. This method was then employed to produce a 
cylindrical gel with a mechanical gradient. The consecutive addition of alginate solutions 
of varying concentrations into the mesh mold resulted in a unified gel post-crosslinking 
(Fig. 2-6B). The mesh mold was then modified to produce a hollow tubular gel by adding 
a glass capillary tube through the center of the mold, prior to the addition of alginate. The 
result was an alginate gel tube with an inner and outer diameter of approximately 1.5 mm 
and 5 mm, respectively (Fig. 2-6C and D). 	  	  
 
The last gel method that was developed and described in the present study was for 
the creation of wells within alginate. Using a thin mesh mold and a gel electrophoresis 
comb, the result was a long, thin alginate gel consisting of a row of hollow wells (Fig. 2-
Fig. 2-6. A) Cylindrical alginate hydrogel, B) Gradient gel consisting of different 
concentrations of alginate, dyed with different colors, C) Alginate gel tube prior to 
removing glass tube, D) Resulting alginate gel tube.  
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7). These gels in particular consisted of wells with dimensions of 1 mm x 5 mm, with a 
gel thickness of approximately 2 mm in between each well.  
 
2.3.2. Confirmation of peptide conjugation 
Cell adhesion studies were used as an indirect method of confirming successful 
conjugation of the RGD peptide to the alginate. D1 ORL UVA cells seeded onto RGD-
alginate hydrogels demonstrated cell adhesion at the 24-hr time point, while little to no 
cell adhesion was observed on the unmodified alginate gels (Fig. 2-8A and B). Cell 
number on the RGD-alginate gels appeared to be greater at 72 hours compared to 24 
hours, as cells began to form aggregated clusters (Fig. 2-8D). Live/dead staining 
confirmed viability of these cell clusters (Fig. 2-8F). In contrast, adhered cells remained 
nearly undetected on the unmodified alginate gels at 72 hours post-seeding (Fig. 2-8C 
and E). These results therefore confirmed successful peptide conjugation to the alginate 
polymer backbone. 
Fig. 2-7. Representative image of alginate wells, with 
dimensions of 1 mm x 5 mm. 
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1H NMR results further confirmed conjugation of the peptide to the alginate 
polymer backbone. Figure 2-5 presents the 1H NMR spectra of unmodified alginate (red 
spectrum) and GRGDSP-conjugated alginate (blue spectrum). New peaks between δ4 and 
δ5 were distinctly detected in the spectrum of the RGD-alginate compared to that of the 
unmodified alginate, which can be attributed to the α-hydrogens of the amino acids of the 
peptide (Fig. 2-9). Based on previous 1H NMR studies involving this peptide, these peaks 
Unmodified Alginate RGD-Alginate 
24 hr 
72 hr 
72 hr  
Live/Dead 
Fig. 2-8. Representative bright field images of D1 ORL UVA cells adhered to 
unmodified alginate hydrogel gels (A and C), and RGD-alginate gels (B and D), 24 hr 
and 72 hr post-seeding. Live/dead staining and subsequent fluorescence microscopy 
was performed to confirm cell viability (E and F). Magnification = 10x. 
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have been labeled according to the amino acid to which they are most likely attributed 
(Fig. 2-9) [99, 100]. Additional peaks that were specifically detected in the GRDSP-
alginate spectrum compared to the unmodified alginate spectrum between δ1.8 and δ2.8 
may be derived from β-hydrogens of the peptide (Fig. 2-9).  
 
2.3.3. Young’s modulus values 
Young’s moduli of alginate and RGD-alginate gels were determined from the 
slopes of the linear regions of the stress-strain curves that were plotted after compression 
testing. A representative stress-strain curve is depicted in Fig. 2-10. The results of the 
compression testing indicated average Young’s modulus values of 2.59 ± 0.20, 3.00 ± 
0.15, 7.64 ± 0.51, 7.75 ± 0.46, and 17.3 ± 0.85 KPa for 0.375%, 0.5%, 0.7%, 1.0%, and 
1.5% unmodified alginate, respectively (n=20 per concentration; Table 2-1). No 
§ Alginate 
§ GRGDSP-alginate 
Fig.  2-9. 1H-NMR spectra of unmodified alginate (red) and GRGDSP-alginate 
(blue) in D2O. 
R	  
G	  
D	  
P	  
S	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significant difference was observed between the Young’s modulus values of the 0.375% 
and 0.5% alginate gels, as well as between the 0.7% and 1.0% gels. All other pairs had 
significantly different Young’s moduli.  
 
The Young’s modulus values calculated for the 0.5%, 1.0%, and 1.5% RGD-
alginate gels were 5.10 ± 0.33, 12.78 ± 0.62, and 21.72 ± 2.00, respectively (n=20 per 
concentration; Table 2-1). All three concentrations of RGD-alginate gels had 
significantly greater Young’s modulus values than the corresponding concentrations of 
unmodified alginate (p<0.05). The Young’s moduli for the unmodified alginate gels and 
RGD-alginate gels are plotted together in Fig. 2.11, along with their corresponding linear 
equations of best fit. A strong linear relationship was observed between Young’s 
modulus and alginate concentration for both the unmodified and RGD-conjugated 
alginate gels, with r2 values of 0.9375 and 0.9981, respectively (Fig. 2-11). 
 
Fig.  2-10. Representative stress-strain curve of a 1.5% RGD-
alginate gel. The linear region is denoted at strain values ≥ 0.1.   
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2.4. Discussion 
In the present study, several aspects of alginate gel design were investigated and 
characterized, demonstrating alginate’s potential as a 3-D matrix for in vitro cell and 
Table 2-1. Young’s modulus values for unmodified alginate and RGD-
alginate hydrogels of increasing concentrations. Values with different letters 
as superscripts differ significantly (p<0.05).  
Alginate 
concentration 
(% w/v) 
Young’s 
Modulus  
(KPa) 
RGD-Alginate 
Concentration  
(% w/v) 
Young’s 
Modulus  
(KPa) 
0.375% 2.59 (± 0.20)a  - - 
0.5% 3.00 (± 0.15)a  0.5% 5.10 (± 0.33)d  
0.7% 7.64 (± 0.51)b  - - 
1.0% 7.75 (± 0.46)b  1.0% 12.78 (± 0.62)e  
1.5% 17.3 (± 0.85)c  1.5% 21.72 (± 2.00)f  
Fig. 2-11. Young’s modulus as a function of alginate concentration for 
unmodified (black circle) and RGD-modified (red triangle) alginate gels. The 
plotted lines display the linear equations of best fit for both alginate conditions 
(Unmodified alginate: r2 = 0.9375; RGD-alginate: r2 = 0.9981). 
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tissue models. First, various methods of gel formation were developed to produce 
alginate gels of distinctive forms. Alginate has been widely used in cell/tissue 
encapsulation studies, but previous studies have mainly involved microencapsulation 
processes, producing alginate beads on the micro scale for cell [101-103] and small tissue 
[33, 36, 38] encapsulation. In contrast, the methods described here produced gels on a 
millimeter scale, which can be used for large tissue models such as the pig embryo model 
[50] and growth plate model described later in this thesis. Previous studies investigating 
the uniformity of 500-µm alginate beads created by the external gelation method used 
fluorescently labeled alginate to demonstrate that bead formation results in a radially 
inhomogeneous distribution of alginate, with the least amount of crosslinking located in 
the gel core [104, 105]. Adding a non-gelling salt, such as sodium chloride, to the CaCl2 
crosslinking solution results in greater uniformity, yet an inhomogeneous distribution of 
alginate still occurs [104]. This inhomogeneous distribution is most likely increased in 
the beads made using the methods of this study, due to the large size of the beads (2-3 
mm). However, for the pig embryo project, which requires a large gel for encapsulation, 
this result is preferred due to a more permissive core for growth and a stiffer outer region 
for stability.  
A method for creating cylindrical alginate gels was also established in this study. 
Previous studies involving cylindrical alginate gels have employed the internal gelation 
method to create the gels [15, 106, 107], in which a calcium slurry, usually calcium 
carbonate or calcium sulfate (CaSO4), is mixed into the alginate solution and gelation 
occurs as the calcium slowly leaks from within the alginate [11].  In this case, release of 
the calcium is caused by a reduction in pH that may be harmful to cells that are within the 
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alginate solution during gelation [11]. The method described in this report for creating 
cylindrical alginate gels instead uses the external gelation method, involving CaCl2, 
which would not have the harmful effect on cell viability. Furthermore, like the bead 
method, the cylindrical gel method in this study involves radial diffusion of calcium ions; 
however, the radial diffusion only occurs transversely to the center of the gel. Therefore, 
the cylindrical gels created in this study most likely contain an inhomogeneous 
distribution of crosslinking in the transverse direction, with a core axis throughout the 
length of the gel that has the lowest degree of crosslinking due to hindered diffusion. This 
permissive central area may serve to guide embryo/tissue growth in the longitudinal 
direction when cells or embryos are encapsulated within the gel.   
Another approach to maintaining tissue architecture is to provide a physical 
reservoir to direct tissue or embryo growth by creating an environment within the gel in 
which the tissue or embryo can be inserted post-crosslinking. With the both alginate tube 
and well methods, the surrounding hydrogel tube or well can serve as a physical structure 
to potentially direct tissue growth within the hollow cavity. The tubular gels, in 
particular, could serve in multiple applications, as cells can be seeded inside the lumen 
and/or encapsulated within the walls of the tube. Previously, studies establishing methods 
for the creation of tubular alginate gels on a similar scale as the ones presented in this 
study have involved complex mechanisms, such as laser-assisted printing [108] and 
electrodeposition [109]. In contrast, the method described in this study offers a simple, 
gentle process for the creation of alginate tubes. Furthermore, this report is the first to 
demonstrate the formation of wells within alginate. Using the row of wells, embryos 
could be cultured in individual alginate wells yet within the same culture dish to observe 
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any embryo-embryo interactions in vitro without direct contact. Additionally, the row of 
wells can be easily cut to produce separated wells for individual embryo culture. 
In addition to gel formation, chemical modification of alginate was investigated in 
the present study, specifically the covalent attachment of an RGD peptide to the alginate 
polymer backbone. The RGD peptides serve as ligands to cell integrins, which are cell-
surface receptors that integrate with the ECM to mediate cell migration and adhesion [1]. 
As alginate is naturally an inert polymer that is not conducive to cell adhesion [14], a cell 
adhesion study can serve as an indirect method of confirming successful conjugation of 
the peptide. The GRGDSP-modified alginate gels promoted cell adhesion and slow 
proliferation of D1 ORL UVA cells, forming aggregated cell clusters over time. In 
contrast, the unmodified alginate gels promoted little to no cell adhesion. These results 
suggest that the peptide was successfully conjugated to the alginate backbone. The results 
of the GRGDSP-alginate gels support previous studies that used similar methods of RGD 
peptide conjugation to promote cell adhesion [14, 27]. These studies found that low RGD 
peptide densities promoted cell adhesion, slow proliferation, and aggregation into 
clusters, as seen with the gels of the present study; however, spreading and proliferation 
increased with increasing RGD peptide densities [27]. Therefore, future studies could 
investigate higher RGD peptide densities to increase proliferation effects and overcome 
clustering. Successful peptide conjugation was further confirmed by 1H-NMR 
spectroscopy, which has previously been used to confirm RGD peptide conjugation to 
polymers [100]. For tissue engineering applications, the unmodified alginate gels can 
serve to solely provide 3-D support for cell/tissue growth, while the RGD-alginate gels 
	   45 
can function to promote cell-matrix interactions via cellular adhesion and 
mechanotransduction [110].  
Stiffness, in particular Young’s modulus, of alginate gels was another property 
that was investigated in this study. Stiffness is the most common mechanical cue 
experienced by cells, with a range of 0.1 kPa to 40 kPa for native soft tissues [111]. The 
results of the present study demonstrate that alginate gels made with our methods are 
within this stiffness range, validating the use of alginate as a 3-D matrix to mimic native 
soft tissues [6].  Furthermore, the results of this study demonstrate that Young’s modulus 
increases with increasing alginate concentration following a linear trend, which supports 
results found in previous studies [15]. Surprisingly, we found that GRGDSP conjugation 
to alginate resulted in Young’s moduli that were significantly greater than unmodified 
gels of the same concentrations, despite the fact that RGD peptide conjugation lowers the 
amount of carboxyl groups available for ionic crosslinking. These results were 
unexpected, as a previous study demonstrated that low RGD peptide concentrations did 
not have a significant effect on compression modulus and that higher amounts of peptide 
conjugation resulted in a lower modulus [112]. The Young’s moduli for both alginate 
conditions, however, are all within the stiffness range of native soft tissue and the largest 
difference detected between the unmodified and modified alginate gels was only ~5 KPa.  
It is also important to note that the unmodified alginate used in these studies was not 
subjected to the same buffer dissolution and subsequent lyophilization process as the 
peptide-conjugated alginate, which could serve as a reason for the difference in 
mechanical properties between the resulting gels.  
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In conclusion, this study demonstrates that alginate hydrogels can be easily 
manipulated in regards to gel formation, bioactive properties, and mechanical properties, 
making it a suitable material for use as a 3-D matrix in in vitro culture models. Each of 
the characteristics explored in this study can be tested for its effect on embryo 
development for the in vitro pig embryo model described in Chapter 3, as well as for its 
effect on chondrocyte function and arrangement for the in vitro growth plate model 
described in Chapter 4. Optimal gel conditions can then be determined in order to 
establish in vitro models that best mimic in vivo conditions, in order to evaluate factors 
and mechanisms involved in normal and abnormal development; knowledge of these 
mechanisms could be used to enhance strategies for increasing pregnancy outcomes (pig 
embryo project) and for engineering growth plate cartilage with proper architecture and 
function (growth plate project). 
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CHAPTER 3 
In vitro development of pre-implantation porcine embryos using alginate hydrogels 
as a three-dimensional extracellular matrix 
 
3.1. Introduction 
In the pig, the pre-implantation period of pregnancy is characterized by several 
developmental hallmarks.  Between day 10 and 12 of gestation, the porcine embryo 
undergoes a process known as elongation, transforming from a ~1-mm spherical structure 
to a long, thin filament >100 mm in length [113, 114].  Unlike elongation in other 
domestic species, rapid elongation of the pig embryo occurs via cellular remodeling and 
differentiation of the trophectoderm rather than cellular hyperplasia [113, 114].  During 
elongation, the embryo produces and secretes estrogen, which serves as a key molecular 
signal for maternal recognition of pregnancy and modulates the production of proteins 
and growth factors within the uterus [115].  Adequate elongation and successful 
implantation of the porcine embryo subsequently affect embryo spacing in the uterus, 
placental development, and fetal growth, which have implications on uterine capacity, 
litter size and postnatal piglet health [78, 116].  
Approximately 20 percent of embryonic loss occurs during the pre-implantation 
period of pregnancy in the pig, with a significant portion of these losses occurring due to 
deficiencies in embryo elongation [77].  Early embryonic loss is poorly understood 
because exact physiological mechanisms by which the embryo elongates, and how these 
mechanisms are altered during embryonic loss, are not clear.  Developing details of the 
mechanisms that regulate embryo elongation can allow for identification of specific 
biophysical, biomechanical, and molecular factors that could serve as targets for 
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improving pregnancy outcomes and neonatal piglet survival.  An effective in vitro culture 
system that supports pig embryo elongation could be used to evaluate specific 
mechanisms of elongation.  To date, attempts to initiate elongation in porcine embryos in 
vitro have been unsuccessful compared to other livestock species [81].  In cattle, limited 
elongation of embryos in vitro via physical induction was demonstrated using an agarose 
gel tube system [48, 49, 80].   However, embryos cultured in this system had deficiencies 
in the development of the embryonic disk [49, 81], which may have been the result of 
forced growth of the embryos to fill the tubes.  Nevertheless, attempts to repeat these 
results using porcine embryos have been unsuccessful [81]. 
Alginate is a commonly used biomaterial, often employed as an artificial 
extracellular matrix in tissue engineering applications [8]. Alginate is a linear 
polysaccharide derived from brown algae composed of repeating units of β-D-mannuronic 
acid and α-L-guluronic acid [117]. One of the favorable properties of alginate as a 
biomaterial is its ability to form a hydrogel by ionic cross-linking of the guluronic 
residues in the presence of a divalent cation [118].  The alginate gel forms a mesh-like 
structure that permits diffusion of nutrients and hormones essential for cell and tissue 
growth and development [117].  Furthermore, alginate promotes negligible non-specific 
protein adsorption and cell adhesion, making it a suitable material for solely examining 
mechanical influence on tissue morphogenesis [14, 119]. We hypothesize that previous 
failure of porcine embryos to elongate in vitro is, at least to an extent, due to inadequate 
culture systems lacking three-dimensional (3-D) structure for proper biomechanical 
support of embryo elongation. Traditional two-dimensional (2-D) cultures result in a 
disruption of cell-to-cell interactions as cells attach to the substrate and migrate away 
	   49 
from the tissue [33, 45].  Three-dimensional culture systems, alternatively, can maintain 
embryo architecture and allow for direct physical interaction with the surrounding 
environment, which better mimics in vivo development.  Therefore, our objective was to 
use alginate hydrogels to establish an in vitro culture system based on tissue engineering 
principles (i.e. 3-D scaffolds) that can mechanically support the culture of pre-
implantation porcine embryos, ensure proper internal biomechanics, and initiate 
morphological changes.  In the present study, in vitro development was evaluated by 
characterizing cellular survival, morphological changes, gene expression of steroidogenic 
and immunological transcripts, and estradiol 17-β (E2) production from porcine embryos 
encapsulated (ENC) in alginate hydrogels or remaining as non-encapsulated controls 
(CONT).    
 
3.2. Materials and methods 
3.2.1. Production and collection of embryos 
All animal protocols were approved by the USMARC Animal Care and Use 
committee and met the USDA guidelines (1995) for the care and use of animals.  Fifteen, 
normally cycling White crossbred gilts consisting of Landrace, Yorkshire and Duroc 
genetics were checked daily for estrus.  Following first detection of estrus (designated as 
d 0), gilts were artificially inseminated with semen from a single Duroc sire with three 
sires represented across the replicate collections (International Boar Semen, Inc., Eldora, 
IA) and again 24 h later with the same sire.  In three independent replicate collections, 
five gilts were slaughtered at the USMARC abattoir at d 9, 10, or 11 of gestation.  
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Following slaughter, reproductive tracts were removed immediately and each uterine 
horn was flushed with 20 mL (~37º C) of Hepes-buffered RPMI-1640 media (Invitrogen, 
Carlsbad, CA) containing 1x antibiotics/antimycotics (Sigma-Aldrich, St. Louis, MO).  
Embryos were recovered and classified according to size and morphology using a 
standard stereomicroscope.  Embryos were then washed with Hepes-buffered RPMI-1640 
media containing 1x antibiotics/antimycotics and 10% heat-inactivated fetal bovine 
serum (FBS; Invitrogen).  From homogenous litters, spherical embryos (~1 mm in 
diameter with a range of 0.5 to 1.5 mm) recovered from gilts at d 9 of gestation (n = 3 
gilts per replicate) were randomly assigned to the in vitro culture treatments (ENC or 
CONT); a subset of these embryos were collected and snap frozen individually in liquid 
nitrogen to serve as initial in vivo-produced spherical control embryos for transcript 
expression.  From homogenous litters, ovoid (5-10 mm in diameter) or tubular (>10 mm 
in diameter with a range of 11 to 20 mm) embryos from the remaining gilts were 
recovered at d 10 or 11 of gestation, respectively (n = 1 gilt per day per replicate) and 
snap frozen individually in liquid nitrogen to serve as later-stage in vivo-developed 
control embryos for transcript expression.  Uterine flushings from all pregnant gilts were 
collected, centrifuged to remove cellular debris and stored at -20°C for later E2 and 
protein analysis. 
 
3.2.2. Embryo encapsulation and culture 
Embryos assigned to the ENC group were encapsulated within alginate hydrogels, 
using a double encapsulation method (Fig. 3-1).  Briefly, sodium alginate (Pronova UP 
MVG, >60% guluronic acid, 200,000 – 300,000 g/mol, NovaMatrix, Norway) was 
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dissolved in sterile MilliQ water to a final concentration of 0.7% (w/v).  Droplets of 
warmed, sterile alginate solution were placed onto polystyrene culture dishes.  A single 
embryo was pipetted into each droplet of alginate in a minimal amount of media as not to 
dilute the alginate solution.  Each droplet was then pipetted into a warmed, sterile cross-
linking solution (50 mM CaCl2, 140 mM NaCl) and allowed to gel for 3 minutes.   
 
The resulting alginate beads with encapsulated embryos were then rinsed twice in 
Hepes-buffered RPMI-1640 media containing 1x antibiotics/antimycotics and 10% FBS.  
Following the rinse, each bead was encapsulated in a second layer of alginate, using 
identical methods as described above for the initial encapsulation, to ensure complete 
Fig. 3-1. Schematic illustration of the double encapsulation method. 1) Embryo is 
transferred into alginate droplet. 2) Droplet is pipetted into calcium solution. 3) 
Alginate bead forms around embryo. 4) Alginate bead is transferred to larger droplet of 
alginate. 5) Droplet with bead is pipetted into calcium solution. 6) Second layer of 
alginate forms around embryo.  Following encapsulation, all embryos were washed and 
cultured individually in a single well within 4-well NUNC plates.    
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encapsulation of each embryo.  The final resulting beads were then washed once with 
pre-gassed culture media containing RPMI-1640, 1x antibiotics/antimycotics and 10% 
FBS.  ENC and CONT embryos were cultured in individual wells in 4-well NUNC plates 
(Thermo-Scientific, Rochester, NY) with 1 mL of culture media for 96 h at 38.5°C and 
5% CO2 in air with 100% humidity.  
 
3.2.3. Characterization of embryo viability and morphology 
Every 24 h, an image was recorded of each embryo by photographing with a 
SMZ1500 stereomicroscope (Nikon Instruments, Inc., Melville, NY).  Based on visual 
appraisal of these images, embryos were classified into one of three in vitro treatment 
groups: CONT (non-encapsulated control embryos), ENC- (encapsulated embryos with 
no observable morphological change) or ENC+ (encapsulated embryos with observable 
morphological changes).  Embryos undergoing morphological changes were 
characterized by a tubular formation of the embryo within the gel and subsequent 
flattening of this tube with many of these embryos migrating out of the gel forming a 
secondary spherical structure once freely in the culture media (Fig. 3-2C).  At the 
termination of culture, embryo survival was determined by assessment of blastocyst 
fragmentation.  Surviving embryos were characterized with no apparent sign of cellular 
degeneration, whereas dying embryos had significant cellular degeneration resulting in 
blastocyst compaction and darkening of the embryo.  Embryo survival and death were 
confirmed in a subset (n = 10) of embryos using a fluorescein/ethidium bromide live/dead 
staining protocol previously reported [120].  Live/dead staining (green or red, 
respectively) was examined and imaged using an Axioplan2 fluorescence microscope 
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(Zeiss, Inc., New York, NY).  
 
3.2.4. Transcript expression analysis 
At the termination of the 96-h culture period, all embryos were imaged prior to 
Fig. 3-2. Representative illustration of morphological changes observed over 96 h of culture in 
embryos double encapsulated in 0.7% alginate hydrogels or remaining as non-encapsulated control 
embryos, with corresponding cellular survival and death after 96 h of culture. Surviving embryos that 
remained intact with no signs of cellular degeneration were classified into one of three in vitro 
treatment groups: A. CONT (non-encapsulated control embryo with no observable morphological 
change), B. ENC- (encapsulated embryo with no observable morphological change) or C. ENC+ 
(encapsulated embryo with observable morphological changes).  CONT (D.) and ENC- (E.) embryo 
that underwent significant cellular death are characterized with significant cellular degeneration 
resulting in blastocyst compaction and cellular darkening.  The same representative embryo from each 
treatment group is displayed across the different time points of culture and the live/dead staining.  
Black and white scale bar = 1 mm corresponding to morphological images and live/dead staining, 
respectively.  Note, the morphological changes of the ENC+ embryo characterized by a tubular 
formation of the embryo at 48 h that flattens by 72 h resulting in the embryo migrating out of the 
hydrogel by 96 h.  There were no observable differences in cellular survival (green stain) or death (red 
stain) between surviving embryos in the three treatment groups (A., B., and C.); however, a greater 
proportion of dead cells (red stain) were observed in the embryos classified as undergoing cellular 
death (D. and E.).   
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snap freezing in liquid nitrogen.  CONT embryos were frozen in a small volume of 
culture media (~5 µL), whereas ENC embryos were frozen within the alginate hydrogels.  
Preliminary analysis of RNA quality following extraction demonstrated no difference 
when embryos remained encapsulated in the hydrogel vs. de-encapsulating the embryos 
prior to collection and extraction (data not shown).  Whole-cell RNA (wcRNA) was 
extracted from individual embryos that survived (i.e., remaining intact with no cellular 
degeneration observed) throughout the duration of culture using the RNeasy Microkit 
(Qiagen, Valencia, CA) with on-column DNase-I treatment as described by the 
manufacturer.  At the same time, wcRNA was extracted from in vivo-developed control 
embryos (i.e., spherical, ovoid and tubular) that had previously been collected.  
Quantification of the wcRNA was performed with RiboGreen as indicated by the 
manufacturer (Molecular Probes, Inc.; Eugene, OR).   
Using porcine-specific primers previously validated to amplify mRNA specific 
for the long form variant of steroidogenic acute regulatory protein (STAR), cytochrome 
P450 side chain cleavage (CYP11A1), aromatase (CYP19A1), and interleukin-1β (IL1B) 
[121, 122], transcript expression levels were assessed using a two-step, real-time 
quantitative PCR (qPCR) method with a Chromo4 real-time PCR detection system (Bio-
Rad, Hercules, CA).  Briefly, reverse transcription was performed with 1 ng of wcRNA 
from the in vivo-developed controls (i.e., spherical, n = 7; ovoid, n = 11; tubular, n = 6), 
CONT (n = 7), ENC- (n = 13), and ENC+ (n = 9) using the iScript cDNA Synthesis kit 
(Bio-Rad) according to the protocol of the manufacturer.  In addition, a pooled sample of 
wcRNA consisting of 1 ng of wcRNA from all embryo treatment groups represented was 
reversed transcribed to generate a pooled cDNA sample that was used to generate a 
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relative standard curve of cDNA for determining interassay CVs and relative quantity 
(RQ) of transcript expression.  Each qPCR was assayed in duplicate and consisted of 50-
pg equivalents of cDNA, 0.25 µM of the appropriate forward and reverse primers, and 
12.5 µL of 1x iTaq SYBR Green Supermix with ROX (Bio-Rad) in a 25-µL reaction.  All 
PCR conditions included denaturation (95ºC for 2 min) followed by amplification (95ºC 
for 15 sec, 60ºC for 15 sec and 70ºC for 45 sec) for 40 cycles.  Melt-curve analysis and 
gel electrophoresis were used to confirm amplification of a single product of the 
predicted size.    
Expression levels for each transcript were based on the threshold cycle (CT) 
values determined using the Opticon Monitor 3 software (Bio-Rad).  For each transcript, 
two assays were performed containing equal representation of all embryo treatment 
groups and a standard serial dilution of pooled cDNA consisting of 200-pg, 50-pg, 12.5-
pg, 3.12-pg and 0.78-pg equivalents of cDNA.  After converting the exponential CT to the 
linear CT using the formula 2-CT [123], the interassay CV for each transcript was 
determined using the pooled cDNA samples from each assay and the intraassay CV for 
each transcript was an average of all samples from both assays.  The inter- and intra-
assay CVs for STAR were 19.3% and 18.8%, respectively; CYP11A1 were 16.1% and 
18.0%, respectively; CYP19A1 were 14.9% and 20.0%, respectively; and IL1B were 
7.3% and 20.4%, respectively.  Calculation of the RQ value was determined using a 
relative standard curve method by plotting treatment CTs against the logarithmic values 
of standard amounts of pooled cDNA [124].  RQ values are expressed as arbitrary units.   
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3.2.5. Estradiol-17β and protein assays 
Every 24 h, half the culture media (500 µL) in each well was collected, stored at -
20°C for hormone and protein analysis, and exchanged with fresh pre-gassed culture 
media (500 µL).  In addition, wells of culture media alone (MEDIA) were included in 
each replicate and processed similarly to wells containing embryos.  Estradiol-17β and 
protein analyses were performed on culture media at 24, 48, 72 and 96 h from MEDIA (n 
= 8) and cultures containing embryos represented in the qPCR analysis (i.e., CONT, n = 
7; ENC-, n = 13; ENC+, n = 9).  In addition, independent analyses for E2 and protein 
were performed on uterine flushings collected from pregnant gilts at d 9 (n = 9), 10 (n = 
3) and 11 (n = 3).  Culture media and uterine flushings were measured for E2 using a 
radioimmunoassay procedure previously described and validated in swine [121, 125].  
Culture media were ether extracted and measured for E2 in duplicate in one assay with an 
intraassay CV of 12.1%.  Uterine flushings were ether extracted and measured for E2 in 
duplicate in one assay with an intraassay CV of 13.0%.  In addition, culture media and 
uterine flushings were measured for total protein content using a bicinchoninic acid 
protein assay (Pierce, Rockford, IL).  Protein content in culture media was measured in 
duplicate in six assays with inter- and intra-assay CVs of 9.3% and 7.7%, respectively.  
Protein content from uterine flushings was measured in duplicate in one assay with an 
intraassay CV of 2.4%.     
 
3.2.6. Statistical Analysis 
Proportional data for embryo survival and morphological changes following 
culture were analyzed using the Chi-square test and were reported as least-squares means 
	   57 
± standard error of the mean (LSM ± SEM) after calculating with GLIMMIX model 
procedures [126, 127].  Transcript expression data, culture media E2 and protein levels, 
and uterine flushing E2 and protein levels were analyzed using MIXED model 
procedures and results are reported as LSM ± SEM [126, 127].  When a significant F-
statistic was generated, means were separated using Dunnett’s multiple comparison test 
[126, 127].  Means were considered statistically different at P ≤ 0.05 and tendencies 
between P = 0.06 and P = 0.10.  Transcript expression data were categorized into 6 
treatment groups corresponding to in vivo-developed spherical, ovoid and tubular 
embryos and in vitro-cultured CONT, ENC- and ENC+ embryos and the model included 
the fixed effects of treatment, replicate and the random effect of gilt within treatment.  
Culture E2 and protein data were categorized into 4 treatment groups (i.e., MEDIA, 
CONT, ENC- and ENC+) and the model included the fixed effects of treatment, culture 
time, replicate, treatment by culture time interaction, and the random effect of gilt within 
treatment by culture time interaction.  Uterine flushing E2 and protein data were analyzed 
with the model including day of gestation, replicate and the random effect of sire within 
day of gestation.  To remove skewness and normally distribute the data, all transcript 
expression and E2 data were log-transformed prior to statistical analysis and back-
transformed to report observed means.    
 
3.3. Results 
3.3.1. Evaluation of embryo viability and morphology 
Figure 3-2 displays representative morphological changes observed over 96 h of 
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culture of CONT and ENC embryos and their corresponding cellular survival and death 
observed by live/dead staining after 96 h of culture.  The assessment of blastocyst 
degeneration at the termination of culture indicated that there was no significant 
difference (P = 0.22) in survival between the CONT and ENC embryos (Table 3-1).  
Embryo survival and death were further confirmed by live/dead staining a subset of 
embryos, which demonstrated no observed differences in cellular survival or death 
between treatment groups.  Embryos classified as undergoing cellular degeneration had a 
greater proportion of dead cells (red) while surviving embryos had a greater proportion of 
live cells (green) (Fig. 3-2).  Morphological changes were only observed in the ENC 
embryos (Fig. 3-2C), while all CONT embryos remained spherical throughout the culture 
period (Fig. 3-2A; Table 3-1).  The percentage of embryos that underwent morphological 
changes was significantly different between CONT and ENC groups when analyzing all 
cultured embryos (P < 0.05) and only those embryos surviving (P < 0.001; Table 3-1).  
The morphological changes observed in the ENC embryos were characterized by a 
tubular formation of the embryo within the gel and subsequent flattening of this tube with 
many of these embryos migrating out of the gel forming a secondary spherical structure 
once freely in the culture media (Fig. 3-2C).  Although 32% of the surviving ENC 
embryos underwent morphological changes, a significant proportion of ENC embryos 
remained spherical throughout culture (Fig. 3-2B).  As a result, encapsulated embryos 
were further classified as encapsulated embryos with no morphological changes (ENC-) 
or encapsulated embryos with morphological changes (ENC+).   
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Table 3-1.  Summary of embryo survival and observed morphological changes following 96 h of 
culture of either non-encapsulated control porcine embryos (CONT) or porcine embryos double 
encapsulated (ENC) in 0.7% alginate hydrogels1     
 CONT ENC P-value 
n (embryos) 24 71  
Embryo survival (%)2 33.3 ± 9.6 (8) 47.8 ± 5.9 (34) 0.22 
No morphological change from all 
embryos (%) 100 83.1 ± 4.4 0.03 
Morphological change from all 
embryos (%) 0 16.9 ± 4.4 0.03 
Morphological change from surviving 
embryos (%) 0 32.3 ± 8.0 <0.001 
1Values are reported as least-squares means ± SEM as determined using GLIMMIX analysis for the main 
effect of treatment (i.e., control vs. encapsulated embryos).  Significance for the effect of treatment was 
determined using Chi-square analysis.   
2Assessed by lack of blastocyst degeneration.  Numbers in parentheses indicate the number of surviving 
embryos for each treatment group.    
   
3.3.2. Transcript expression levels  
The expression of STAR mRNA was increased (P < 0.05) in all in vitro treatment 
groups (CONT, ENC- and ENC+) compared to the initial in vivo spherical control (Fig. 
3-3A).  However, STAR expression was greater (P < 0.05) in ENC+ embryos compared 
to ENC- embryos and tended to be greater (P = 0.07) in ENC+ embryos compared to 
CONT embryos (Fig. 3-3A).  As a result, the expression pattern of STAR in CONT and 
ENC- embryos was more similar to in vivo ovoid embryos, whereas ENC+ embryos 
displayed an expression pattern of STAR more similar to that of in vivo tubular embryos 
(Fig. 3-3A).  Expression levels of CYP11A1 mRNA were increased (P < 0.05) in all in 
vitro treatment groups (CONT, ENC- and ENC+) compared to their initial in vivo 
spherical controls (Fig. 3-3B).  Furthermore, CYP11A1 expression was greater (P < 0.05) 
in ENC+ embryos compared to CONT and ENC- embryos.  Again as observed with 
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STAR, the expression pattern of CYP11A1 in CONT and ENC- embryos was more similar 
to in vivo ovoid embryos, whereas ENC+ embryos displayed an expression pattern of 
CYP11A1 more similar to that of in vivo tubular embryos (Fig. 3-3A).    
 
Expression levels of CYP19A1 mRNA were greater (P < 0.05) in ENC+ embryos 
compared to CONT and ENC- embryos (Fig. 3-3C).  In addition, ENC+ embryos had an 
expression level of CYP19A1 significantly greater (P < 0.05) than in vivo spherical 
controls, whereas CYP19A1 expression levels were not different between CONT, ENC- 
Fig. 3-3.  Expression levels of A. STAR, B. CYP11A1, C. CYP19A1 and D. IL1B mRNA 
measured by qPCR from in vivo-produced control embryos and in vitro-cultured CONT (non-
encapsulated control), ENC- (encapsulated with no observable morphological changes) and 
ENC+ (encapsulated with observable morphological changes) embryos.  Data were log-
transformed before analysis and back-transformed to observable values.  Least-squares means 
± SEM values are expressed as a relative quality (RQ).  Statistical analysis demonstrated that 
embryo treatment had significant effects on the expression level of A. STAR (P < 0.01), B. 
CYP11A1 (P < 0.001), C. CYP19A1 (P < 0.01) and D. IL1B (P < 0.01).  RQs with different 
superscripts for each transcript are significantly different (P < 0.05).   
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and in vivo spherical controls (Fig. 3-3C).  Furthermore, expression of CYP19A1 was 
decreased (P < 0.05) in CONT and ENC- embryos compared to in vivo ovoid and tubular 
embryos (Fig. 3-3C).  In contrast, CYP19A1 expression did not differ between ENC+ and 
the later-stage in vivo ovoid and tubular embryos, although the expression pattern was 
numerically more similar in ENC+ and in vivo ovoid embryos (Fig. 3-3C).  No 
significant differences were detected in expression levels of IL1B mRNA between 
CONT, ENC- and in vivo spherical controls (Fig. 3-3D).  However, IL1B expression was 
increased in the ENC+ embryos compared to CONT and in vivo spherical controls (Fig. 
3-3D).  Furthermore, expression of IL1B did not differ between ENC+ and in vivo ovoid 
embryos, but was significantly (P < 0.05) decreased in ENC+ compared to in vivo tubular 
embryos.   
 
3.3.3. Estradiol-17β and protein analysis 
A significant time-dependent increase (P < 0.001) in E2 levels in the culture 
media of encapsulated embryos (both ENC+ and ENC-) was identified compared to 
culture media from CONT embryos and culture media alone (Fig. 3-4A). Culture media 
from all embryo groups (i.e., CONT, ENC- and ENC+) had greater (P < 0.05) E2 levels 
than media alone after 96 h of culture (Fig. 3-4). Culture media containing ENC+ 
embryos had significantly greater levels (P = 0.05) of E2 compared to CONT and ENC- 
embryos at 72- and 96-h time points (Fig. 3-4A).  In contrast, culture media containing 
ENC- embryos displayed an intermediate but significantly different (P < 0.05) level of E2 
between ENC+ and CONT embryos at 96 h (Fig. 3-4A).  A similar pattern of increased 
(P < 0.05) E2 production was observed in uterine flushings as pregnancy progressed from 
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9, 10 and 11 of gestation with the greatest levels of E2 in uterine flushings at d 11 of 
gestation (Fig. 3-4B). 
 
 
Results from the protein assay indicate that no significant differences were 
detected for total protein levels in culture media containing MEDIA alone, CONT, ENC-, 
or ENC+ embryos (Fig. 3-5A).  In contrast, there tended (P = 0.09) to be a time-
dependent increase in total protein levels from uterine flushings as pregnancy progressed 
from d 9, 10 and 11 of gestation (Fig. 3-5B).  
 
Fig. 3-4. A. Estradiol-17β (E2) concentrations (pg/mL) in culture media collected at 24-, 48-, 72- and 96-
h of culture containing only media (MEDIA), non-encapsulated control embryos (CONT), encapsulated 
embryos with no observable morphological change (ENC-) and encapsulated embryos with observable 
morphological changes (ENC+).   B. E2 concentrations (pg/mL) in uterine flushings from pregnant gilts 
at d 9, 10 and 11 of gestation.  Data were log-transformed before analysis and back-transformed to 
observed values and presented as least-squares means ± SEM.  Statistical analysis demonstrated a 
significant (P < 0.001) culture media treatment by culture time interaction for E2 concentration in which 
culture media containing ENC+ embryos had greater E2 concentration compared to MEDIA, CONT and 
ENC- groups at 72- and 96-h.  Statistical analysis demonstrated a significant (P < 0.05) gestational day 
effect for E2 concentration in uterine flushings.	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3.4. Discussion 
In the present study, alginate hydrogels were employed as 3-D matrices to support 
in vitro culture of porcine embryos during the pre-implantation period.  Previously, 
alginate hydrogels have been used to support in vitro development of early blastocysts in 
cattle [38], as an artificial zona pellucida for mouse morulae [128] and for the culture of 
ovarian follicles in mice [15, 33, 37, 129] and nonhuman primates [34].  However, this 
report is the first to demonstrate the use of alginate hydrogels for porcine embryo culture.  
For those studies involving the encapsulation of early bovine embryos, 1.5% alginate 
hydrogels supported similar blastocyst rates as 2-D controls; however, the alginate 
system resulted in decreased blastocyst hatching rates, suggesting that the percentage of 
alginate may have formed a matrix that was too rigid to allow for hatching [38].  Studies 
involving mouse ovarian follicle culture investigated mechanical properties of alginate 
Fig. 3-5.  A. Total protein (mg) in culture media collected at 24-, 48-, 72- and 96-h of culture containing 
only media (MEDIA), non-encapsulated control embryos (CONT), encapsulated embryos with no 
observable morphological change (ENC-) and encapsulated embryos with observable morphological 
changes (ENC+).  B. Total protein (mg) in uterine flushings from pregnant gilts at d 9, 10 and 11 of 
gestation.  Data are presented as least-squares means ± SEM.  Statistical analysis demonstrated no 
significant (P > 0.10) effects for total protein collected from the culture media at 24-, 48-, 72- and 96-h of 
culture.  Statistical analysis demonstrated a tendency (P = 0.09) for increased total protein in uterine 
flushings at d 11 of gestation compared to d 9, with d 10 demonstrating an intermediate level of protein.	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gels of varying concentrations and demonstrated that decreasing alginate matrix stiffness 
enhanced follicle growth [15], linking biomechanical environmental factors with 
cell/tissue development and function.  Specifically, these studies demonstrated that 0.7% 
alginate, the lowest concentration of alginate that was tested, formed a low-stiffness 
hydrogel that was the most permissive to mouse follicle growth, cellular differentiation 
and corresponding steroid production [15].  Based on these findings, 0.7% alginate was 
used in the present study in order to provide sufficient mechanical support to properly 
maintain porcine embryo development, without inhibiting growth or survival.   
 Our in vitro culture system utilizing alginate hydrogels was able to facilitate 
morphological changes of pre-implantation porcine embryos by applying a tissue 
engineering approach to embryo culture.  Although survival rates did not differ between 
the encapsulated and non-encapsulated embryos, morphological changes were only 
observed with embryos encapsulated in alginate hydrogels.  The inability of the non-
encapsulated control embryos to undergo morphological changes in vitro suggests that a 
3-D matrix is required to maintain appropriate embryo architecture for proper 
development during the elongation stage of gestation.  These results support the findings 
of previous studies that demonstrated that both mechanical forces, generated from the 
stiffness of surrounding tissues or substrates, and cell-generated contractility regulate 
differentiation during embryonic development [96].  Our in vitro culture system 
employing alginate hydrogel as a 3-D matrix may be initiating embryo morphological 
change by stimulating biochemical signals within the embryo via mechanotransduction 
[96, 97], or by simply providing support for the 3-D structure of the embryo to maintain 
its cell-to-cell communication, a feature that traditional culture systems have been 
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lacking.  The requirement of the 3-D structure as a necessity to support morphological 
changes can further be supported by the observation that when ENC+ embryos within our 
culture system exited the alginate hydrogel, they formed a secondary spherical structure 
likely due to fluid transport into the trophectoderm, which was observed in the non-
encapsulated CONT embryos that did not have 3-D support.       
Though the percentage of total encapsulated embryos that exhibited 
morphological changes (17%) may seem lower than ultimately desired, it is important to 
emphasize that if the encapsulated embryo survives within our newly developed in vitro 
system, it has a relatively high chance of initiating morphological changes (32%) in 
simple basal media conditions.  In a previous study involving in vitro culture of bovine 
embryos in agarose gel tunnels, high levels of glucose in the culture medium may have 
resulted in rapid cell growth, contributing to the appearance of embryonic elongation 
[49].  Conversely, in the present study, no particular growth factors or nutrients were 
added to the culture medium, indicating that limited embryonic morphological changes 
can occur in vitro within alginate hydrogels without the addition of special media 
supplements.  While the percentage of porcine embryos initiating morphological changes 
in the current study is significantly less than reported in studies culturing bovine embryos 
in the agarose gel tunnel system, ranging from 54% to 88% [48, 49, 80], it is important to 
highlight that these bovine studies with a high percentage of morphological changes were 
performed using embryos that were strictly produced in vitro and these embryos were 
selectively chosen as high quality in vitro-produced embryos prior to being placed into 
the agarose gel tunnel system [48, 49, 80].  In contrast, the current study only used in 
vivo-produced embryos collected at d 9 of gestation in the pig.  A previous study that 
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investigated morphological changes using in vivo-produced bovine embryos within the 
agarose gel system reported a very low percentage (3%) of in vivo-produced bovine 
embryos that initiated morphological changes following in vitro culture in the agarose gel 
system [82].  This finding, in conjunction with the findings of the current study, 
illustrates that in vivo-produced embryos are not as efficient as in vitro-produced embryos 
at initiating morphological changes within in vitro culture systems, which is likely the 
result of the dramatic environmental change that in vivo-produced embryos experience 
going from the uterine environment to an in vitro environment. Therefore, the percentage 
of embryos that underwent morphological changes in the current study (i.e., 17%) is 
relatively high for a study involving in vivo-produced embryos within an in vitro culture 
system, with only basal culture media. 
Several transcripts, such as steroidogenic transcripts (i.e., STAR, CYPY11A1 and 
CYP19A1) and immune responsive transcripts (i.e., IL1B) are increased in a similar 
pattern as estrogen production during embryo elongation [130, 131].  According to the 
results of the present study, STAR expression levels for ENC+ embryos were similar to 
tubular in vivo embryos, but greater than ovoid in vivo embryos.  In contrast STAR 
expression in CONT and ENC- embryos remained similar to ovoid in vivo embryos.  
STAR, which is a major initiator of steroidogenesis [132], has previously been found to be 
more abundantly expressed in elongated filamentous embryos than in ovoid embryos 
[131].  Therefore, our STAR expression results suggest that embryos undergoing 
morphological changes within alginate hydrogels exhibit similar STAR expression trends 
as those that occur during initiation of elongation in vivo.  Similar gene expression 
patterns were found with CYP11A1 and CYP19A1 within our in vitro culture system, 
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which are the two additional transcripts encoding for rate-limiting proteins required for 
estrogen synthesis [131].  CYP11A1 and CYP19A1 expression levels were increased in 
ENC+ embryos compared to CONT and ENC- embryos.  These findings further suggest 
that encapsulated embryos that transformed morphologically during culture also changed 
at the level of gene expression, corresponding to the morphological transition and 
differential steroidogenic gene expression that occurs during the onset of elongation in 
vivo.  
Proper interactions between the embryo and receptive uterine endometrium are 
also essential for supporting embryonic development and subsequent implantation [67].  
These interactions are initiated by the immune responsive cytokine IL1B, which is 
increased by the embryo during elongation and may be responsible for preventing 
conceptus rejection via suppressing the maternal immune response [67].  Although our 
results demonstrate that the expression of IL1B was greater in ENC+ embryos compared 
to CONT embryos, the expression pattern was decreased in the ENC+ compared to 
tubular in vivo embryos.  This outcome may suggest that direct interaction with the 
maternal endometrium is likely required for up-regulation of IL1B in the embryo, while 
up-regulation of steroidogenic transcripts may be independent of maternal-embryonic 
cross-talk.    
In vivo estrogen production by the porcine embryo increases during the elongation 
stage, stimulating the synthesis and release of numerous endometrial secretory proteins, 
which is essential for establishing maternal recognition of pregnancy [115, 130].  Our 
results indicated that the ENC+ embryos produced and secreted a greater amount of E2 
by 72 and 96 h of culture compared to the CONT and ENC- embryos.  In addition, this 
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up-regulation of E2 in the culture media of ENC+ embryos was independent of increased 
production of total protein within the culture media.  These results correspond with the 
increased expression of steroidogenic transcripts STAR, CYP11A1, and CYP19A1 in the 
ENC+ embryos, which supports previous findings of the direct correlation between these 
transcripts and steroid synthesis [131, 132].  Therefore, the E2 results further suggest that 
embryonic morphological changes induced by the alginate hydrogel culture system are 
indications of initiation of elongation due to the corresponding increase in estrogen 
production.  The time-dependent increase in E2 observed in the culture media of ENC+ 
embryos followed a similar trend as observed for E2 levels in the uterine flushings as 
pregnancy advanced through this time period, with the greatest production of estrogen 
observed at d 11 of gestation when tubular embryos were present. Furthermore, protein 
increased in the uterine flushings as pregnancy advanced.  Given that protein increases 
within the uterine milieu regardless of pregnancy status [133], increased expression of 
steroidogenic transcripts and E2 production by ENC+ embryos without a difference in 
protein levels within the culture media further suggests that up-regulation of 
steroidogenesis and subsequent estrogen production may be independent of maternal-
embryonic cross-talk.   It is important to highlight that there was a 48-h delay for 
embryos cultured within alginate hydrogels to initiate production and secretion of E2 into 
the culture media, as well as for significant morphological changes to occur, which 
indicate a delay in development for in vitro-cultured embryos compared to in vivo-
developed embryos.  A similar delay in morphological changes was observed in bovine 
embryos cultured in the agarose gel system compared to in vivo-developed embryos [82].  
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This delay is likely due to the embryos recovering from the encapsulation technique and 
adjusting to the in vitro microenvironment.   
Unlike elongation in other domestic animals, rapid elongation of the pig embryo 
has been primarily associated with cellular remodeling and differentiation rather than 
hyperplasia [61].  As a result, follow up studies investigating potential markers for 
differentiation of the trophectoderm and mesoderm would be useful for measuring the 
level of differentiation from embryos undergoing morphological changes within our in 
vitro culture system.  Furthermore, embryonic disc establishment, which was not 
monitored in the current study, will be included in follow-up studies to further evaluate 
the efficiency of our culture system.  Monitoring the formation of the embryonic disc will 
be a useful technique for measuring the synchrony between trophoblast and embryonic 
disc development as we move forward to improve our in vitro culture system using 
alginate hydrogels. 
In conclusion, the present study demonstrates an in vitro culture system that can 
support porcine embryo development during initiation of elongation.  Our culture system, 
which employs alginate hydrogel as a 3-D extracellular matrix for porcine embryo 
culture, has proven to facilitate embryonic morphological changes with corresponding 
increases in steroidogenic transcript expression and estrogen production, in a similar 
pattern as observed in in vivo-developed embryos.  Our findings advocate the potential of 
our alginate culture system as an in vitro tool for evaluating and understanding specific 
mechanisms of embryo elongation.  Further investigations with our 3-D in vitro culture 
system can focus on the effects of certain growth factors, hormones, ligands, and uterine 
epithelial cell co-culture on development of pre-implantation porcine embryos.  Specific 
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factors regulating pig embryo elongation can be identified to develop strategies to 
improve pregnancy outcomes in the pig.  Identified factors could then be manipulated 
through either direct intervention or marker-assisted selection of genomic markers to 
improve early embryonic survival, uterine capacity, and pre-weaning piglet survival, 
which could have a significant impact on the profitability of swine production.  
Furthermore, our alginate culture system could be applied to embryos of other ungulate 
species, such as cattle and sheep that also undergo embryo elongation during the pre-
implantation period of pregnancy, in order to identify potential regulators of normal 
embryonic development in a variety of species.   
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CHAPTER 4 
The effect of parathyroid hormone and RGD peptide ligands on the in vitro 
behavior of growth plate chondrocytes within 3-D alginate matrices 
 
4.1. Introduction 
Osteochondrodysplasias, a group of disorders characterized by abnormal growth 
and remodeling of bone and cartilage, occur with over 200 different phenotypes, with a 
prevalence estimated to be between 1 in 3000 to 1 in 5000 births [88]. Mutations 
responsible for these dysplasias may cause defects in the synthesis of extracellular matrix 
proteins, specific growth factors, receptors, and transcription factors, leading to short 
stature and/or cranial defects [89]. Furthermore, skeletal growth can be affected by 
defects in growth plate function due to radiation and chemotherapy as well as cartilage 
injury from sports and high impact activities [134, 135]. In addition to affecting quality of 
life, growth plate damage due to injury or disease is often associated with long-term 
intensive health care needs due to impact on the joints, the central nervous system, and 
the ocular system [90, 91]. As cartilage does not heal, strategies to replace damaged or 
diseased cartilage through tissue engineering or regenerative approaches are of great 
interest.  
Within growth plate cartilage, chondrocytes differentiate in a spatially regulated 
manner that results in morphologically and functionally distinct zones of cells, forming a 
continuum from progenitor cells (resting chondrocytes) to terminally differentiated, 
hypertrophic chondrocytes [83, 85] (Fig. 4-1). The middle proliferative zone is 
distinguished by a columnar arrangement of flattened chondrocytes regulated by an 
indirect, functional feedback loop between the secreted proteins parathyroid hormone 
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related protein (PTHrP) and Indian hedgehog (Ihh), produced by resting and early 
hypertrophic chondrocytes, respectively [83-85]. Prehypertrophic chondrocytes exiting 
the proliferative columns express Ihh, which stimulates the production of PTHrP by 
resting cells and perichondral cells located at the bone ends [83, 85].  
 
PTHrP receptors are expressed at low levels in chondrocytes of the proliferative 
zone and high levels in the pre-hypertrophic chondrocytes as they transition from the 
proliferative to hypertrophic state [83, 136]. PTHrP primarily acts to keep these cells in 
the proliferative pool, delaying further differentiation [83, 137]. As chondrocytes in the 
proliferative columns become too distant from the PTHrP-producing cells located at the 
bone ends, PTHrP concentration becomes too low to stimulate them; this lack of 
stimulation causes the chondrocytes to stop proliferating, enter a pre-hypertrophic 
maturation phase, and begin to synthesize Ihh, thereby forming a feedback loop that 
controls the length of the proliferative columns and site of hypertrophic differentiation 
Resting chondrocytes 
Proliferative chondrocytes 
Prehypertrophic chondrocytes 
Hypertrophic chondrocytes 
Perichondral cells 
Ihh 
Type II collagen, 
hyaline cartilage 
matrix 
Type X collagen, 
calcifying matrix  
PTHrP 
Fig. 4-1. Schematic illustration of zonal arrangement of chondrocytes and 
Ihh/PTHrP feedback loop within the growth plate. 
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[83, 137]. The chondrocytes of the resting and proliferating zones are also characterized 
by the secretion of structural proteins, predominately type II collagen, while hypertrophic 
cells primarily synthesize type X collagen and begin to remodel the cartilage matrix into 
a calcifying matrix [83-85]. 
Although significant advances have been made in discovering signaling pathways 
and gradients that regulate growth plate function, it remains unclear whether these factors 
alone are sufficient to induce normal growth plate structure and function. Previous 
attempts to engineer growth plate cartilage have failed to produce native cartilage 
architecture, in particular a distinct zone of proliferating columnar chondrocytes, 
suggesting that these factors are not enough to replicate proper structure in vitro. 
Therefore, an effective in vitro model of the growth plate could serve as the necessary 
tool for further evaluating specific mechanisms that regulate proper growth plate 
structure and function. Understanding these mechanisms by studying the generation of 
growth plate architecture in vitro is critical for enhancing tissue engineering strategies in 
order to provide optimal replacement tissue for abnormal or damaged growth plates.  
We hypothesize that a three dimensional (3-D) matrix with appropriate 
biomechanics, extracellular matrix (ECM) factors, and signaling gradients can establish 
an in vitro model of native growth plate cartilage. The objective of the current study was 
to first investigate the effect of parathyroid hormone (PTH) on isolated mouse growth 
plate chondrocytes in vitro, encapsulated within alginate hydrogels as the 3-D artificial 
matrix. Alginate is a linear polysaccharide composed of repeating units of β-D-
mannuronic acid (M) and α-L-guluronic acid (G) [9] that forms a hydrogel by ionic cross-
linking of the G residues in the presence of a divalent cation [10]. In addition to its gentle 
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gelation process and high porosity for diffusion of nutrients and growth factors [7, 13], 
alginate promotes negligible non-specific protein adsorption and cell adhesion [14], 
allowing alginate to act as a “blank slate” into which specific cell-matrix interaction 
factors can be added. The arginine-glycine-aspartic acid (RGD) peptide sequence, which 
is found in extracellular matrix proteins of cartilage such as collagen, fibronectin, 
laminin, is the most effective and commonly used peptide sequence to promote cell 
adhesion [43]. When covalently linked to alginate, RGD peptide sites serve as ligands to 
cell integrins to mediate cell migration and adhesion. Therefore, RGD peptide 
conjugation to alginate was the second factor investigated in this study for its effect on in 
vitro growth plate chondrocyte behavior. In vitro chondrocyte behavior within 
unmodified and RGD-conjugated alginate gels, with and without PTH treatment, was 
evaluated by characterizing cellular proliferation and analyzing gene expression of 
transcripts involved in chondrocyte hypertrophy.   
 
4.2. Methods 
4.2.1. Preparation of alginate solutions 
 
For the unmodified alginate condition, sodium alginate (Pronova UP MVG, >60% 
guluronic acid, 200,000 – 300,000 g/mol, NovaMatrix, Norway) was dissolved in sterile 
1X phosphate buffered saline (1X PBS) to a final concentration of 1.5% (w/v). For the 
RGD peptide treatment, alginate was covalently modified with a GRGDSP peptide 
(Anaspec, Fremont, CA) to a concentration of 4 µmol/g alginate using carbodiimide 
chemistry, as previously described [14]. Briefly, two grams of sodium alginate were 
	   75 
added to 200 mL of MES buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was 
allowed to dissolve for 7-8 hours on a stir plate. 1-ethyl-(dimethylaminopropyl) 
carbodiimide (EDC; Sigma Aldrich, St. Louis, MO) was added to activate 5% of the 
uronic acids of the alginate polymer backbone in order to form amide linkages with the 
peptide. To stabilize the reactive EDC intermediate against a competing hydrolysis 
reaction, N-hydroxy-sulfosuccinimide (sulfo-NHS; Pierce, Rockford, IL) was also added 
to the solution at a 2:1 EDC to NHS ratio. Lastly, the GRGDSP peptide was incorporated 
into the solution, conjugating to the alginate backbone via the terminal amine of the 
peptide. After 20 hours of reacting, the conjugation reaction was quenched through the 
addition of hydroxylamine hydrochloride (Sigma Aldrich). The alginate solution was 
then dialyzed against decreasing salt solutions and finally ddH2O over the course of 3 
days. The final dialyzed solution was lyophilized to dryness and dissolved in 1X PBS to a 
final concentration of 1.5% (w/v). 
 
4.2.2. Isolation of growth plate chondrocytes 
Growth plate cartilage was dissected from the distal growth plate of the femur and 
the proximal growth plate of the tibia from three- and four-day-old neonatal Swiss 
Webster mice. The growth plate cartilage was then incubated in 1 mL of 0.5% 
collagenase in Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen, Carlsbad, 
CA) with 10% fetal bovine serum (FBS) for 3-4 hours at 37°C and 8% CO2, resulting in a 
suspension of chondrocytes. Next, 10 mL of DMEM with 10% FBS was added to the 
suspension of chondrocytes and centrifuged for 5 minutes at 125 x g. After aspirating the 
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supernatant, the cell pellet was resuspended in 10 mL of DMEM with 10% FBS and cells 
were counted with a hemacytometer.  
 
4.2.3. Chondrocyte encapsulation and culture 
Chondrocytes were cultured in four different treatment groups, as shown in Table 
4-1: unmodified alginate gels without the addition of PTH (Unmodified/no PTH), 
unmodified alginate gels treated with 1 µM PTH (Unmodified + PTH), GRGDSP-
conjugated alginate gels without the addition of PTH (RGD/no PTH), and GRGDSP-
conjugated alginate gels treated with 1 µM PTH (RGD + PTH). Prior to encapsulation, 
chondrocytes were once again pelleted by centrifugation, resuspended in a volume of 
culture media equal to 10% of the volume of alginate, and then mixed into the alginate 
and RGD-alginate solutions to obtain a concentration of 8x106 cells/mL alginate. A 
separate batch of cell/alginate suspension was prepared for each condition. To 
encapsulate the chondrocytes, 10-µL drops of the alginate/cell mixture were placed one at 
a time into crosslinking solution (50 mM CaCl2/140 mM NaCl) for 2 minutes, forming 
cell-embedded alginate hydrogel beads. The beads were then transferred to wells of rinse 
media to leach out excess calcium ions before being placed into fresh wells of cartilage 
culture media (MEM alpha medium without Phenol Red [Invitrogen] supplemented with 
50 µg/mL Penicillin-Streptomycin-Glutamine [Invitrogen], 10 mM β-glycerophosphate, 
and 50 µg/mL ascorbic acid). For the PTH conditions, PTH (Sigma Aldrich) was added 
to the culture media to obtain a final concentration of 1 µM. A total of 9 beads were made 
per condition so that a subset of 3 beads could be analyzed at each time point (Table 4-1). 
Additionally, 4 extra beads were made for the RGD/no PTH condition to perform 
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live/dead staining, which will be described below. The beads were cultured for 3 days, 
with the media replaced every 24 hours. Endpoint analyses were performed on Day 1, 2, 
and 3 of culture as described in the following sections.  
 
 
4.2.4. Characterization of cell viability and proliferation 
Because beads were made sequentially after blending the cells into the alginate 
solution for each condition, some cells were required to remain in alginate solution longer 
than others prior to crosslinking. To determine if this extra time spent in alginate solution 
lowered cell viability, the first bead prepared from the batch of alginate/cell suspension 
for the RGD/no PTH condition, along with the last bead prepared from this batch, were 
live/dead stained after Day 1 of culture. Additionally, one representative bead from the 
same condition (RGD/no PTH) was removed from culture on Day 2 and Day 3 for 
live/dead staining to evaluate cell viability over the course of the culture period. These 
beads were rinsed twice with 1X tris-buffered saline with 1.8 mM CaCl2 (1X TBS + 1.8 
mM CaCl2) and then placed into 1xTBS with 2 µM calcein AM and 4 µM ethidium 
Table 4-1. Overview of number of beads per culture condition and per endpoint analysis. 
Total number of beads per condition were divided up between the three time points (Days 1, 
2, and 3) so that a subset could be taken on each day for analysis. Live/dead staining for the 
RGD + PTH condition was performed on Day 1 for the first and last beads made for that 
condition, and on a representative bead at Days 2 and 3.  
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homodimer-1 for 30 minutes to stain live and dead cells, respectively. After another rinse 
in 1X TBS + 1.8 mM CaCl2, the beads were placed on a glass coverslip and imaged using 
an epifluorescence microscope (Leica DMI6000B, Wetzlar, Germany).  
For analysis of cell proliferation on Days 1, 2 and 3 of culture, a subset of beads, 
one from each condition, was analyzed using the Click-iT EdU Imaging kit (Invitrogen, 
Carlsbad, CA), following manufacturer’s instructions. EdU (5-ethynyl-2’-deoxyuridine) 
is a nucleoside analog of thymidine that becomes integrated into DNA during active 
DNA synthesis, serving as a marker for cellular proliferation when covalently bound to a 
fluorescent probe. Briefly, the encapsulated cells were incubated with EdU for 1 hour and 
then fixed in 4% paraformaldehyde with 1.8 mM CaCl2. After rinsing in 1xTBS +1.8 mM 
CaCl2, the beads were embedded in 6% agarose and then sectioned into 300-µm sections 
within a 1xTBS + 1.8 mM CaCl2 bath using a vibratome (Leica). Sections were then 
incubated in the Click-iT reaction cocktail consisting of an Alexa Fluor azide to detect 
EdU incorporation. Finally, cellular DNA was stained with Hoechst 33342 to identify 
nuclei. The cells were then imaged using an epifluorescence microscope (Leica 
DMI6000B). The Volocity software (Perkin Elmer, Waltham, MA) was used to perform 
deconvolution of z-stacks to remove background fluorescence and then used to count 
total number of cells in each section (one section per condition), as well as cells that 
stained positively for EdU, to determine percent proliferation. 
 
4.2.5. Transcript expression analysis 
Real-time PCR (RT-PCR) was used to analyze expression of collagen 10a1 
(ColX), Indian hedgehog (Ihh), and Sox9 (Sox9; marker for chondrocyte differentiation) 
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transcripts. At the specified time points, a subset of alginate beads from each condition 
was taken from culture and dissolved in 50 mM EDTA for 10 minutes to release the cells 
for RNA extraction. Total RNA was extracted using TRIzol reagent following the 
manufacturer’s instructions (Invitrogen). Total RNA was then treated with DNase I 
(Promega, Madison, WI) to remove any genomic DNA and reverse transcribed to cDNA 
using SuperScript III Reverse Transcriptase (Invitrogen) and random primers (Promega) 
combined with oligoDT20 primers (Invitrogen). Real-time PCR was performed using 
ABsolute Blue Sybr Green ROX mix (Thermo Scientific, Waltham, MA) and a 
StepOnePlus System (Applied Biosystems, Carlsbad, CA). Gene specific primers 
designed for the genes specified above are shown in Table 4-2. Data were normalized to 
an endogenous control, actin, using the primers shown in Table 4-2 for β-actin. 
 
 
4.2.6. Statistical analysis 
For RT-PCR results, RQ values are reported as mean ± standard deviation. After 
normalizing to the endogenous control, data within each day were normalized to the 
values for the unmodified/no PTH condition to observe treatment effects. One-way 
analysis of variance (ANOVA) was used to determine if means were statistically 
Table 4-2. Description of the designed primers. 
Target Forward Primer Sequence Reverse Primer Sequence
Collagen 10a1 TTCTGCTGCTAATGTTCTTGACC GGGATGAAGTATTGTGTCTTGGG
Ihh CCCCAACTACAATCCCGACA TCATGAGGCGGTCGGC 
Sox9 ACGGCTCCAGCAAGAACAAG TTGTGCAGATGCGGGTACTG
ß-actin AAATCGTGCGTGACATCAAAGA GCCATCTCCTGCTCGAAGTC
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different. If ANOVA analysis showed a significant difference among the means, Tukey’s 
multiple comparison test was then used to perform pairwise comparisons.  
 
4.3. Results 
4.3.1. Evaluation of chondrocyte viability and proliferation 
After 24 hours of culture, chondrocytes encapsulated in the first and last bead 
prepared from the alginate/cell suspension for the RGD /no PTH condition were live/dead 
stained and compared in order to assess whether extra time spent in alginate solution 
prior to crosslinking affected cellular survival. No considerable differences in cellular 
survival or death were observed between the first and last bead that were made for this 
condition (Fig. 4-2A and 4-2B). In addition, no substantial differences in cell viability 
were observed between Days 1, 2, and 3 of culture within the RGD-alginate gels (Fig. 4-
2C and 4-2D).  
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To identify the number of proliferating chondrocytes in each treatment group 
(Table 4-1), 300-µm sections (one section per condition) were treated with EdU and 
stained for EdU detection. Cellular DNA was then stained to evaluate total number of 
cells in order to calculate the percentage of cells that were positive for EdU staining. 
Representative images are shown in Figure 4-3 and calculated results are presented in 
Table 4-3, with some treatments missing due to loss of sections. No substantial effects of 
RGD ligands or PTH on percent proliferation were observed, as the percentages for each 
treatment group only differed by a few percent at most (Table 4-3). However, despite the 
low percentages for all conditions, the RGD-alginate condition had an approximately 2.5-
fold higher percent proliferation by Day 3 compared to the corresponding unmodified 
Fig. 4-2. Live/dead staining at Day 1 of culture of chondrocytes 
encapsulated in the first (A.) and last (B.) beads that were prepared from 
the RGD/no PTH condition, and representative beads from this batch on 
Day 2 (C.) and Day 3 (D.) of culture. No considerable differences in 
cellular survival (green) or death (red) were observed between the first and 
last bead on Day 1, or between Days 1, 2, and 3 of culture.  
Day 1 – Last bead 
Day 2 
Day 1 – First bead 
Day 3 
A. 
C. 
B. 
D. 
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alginate condition (Table 4-3), and the PTH treatment groups exhibited a 1.3- to 1.5-fold 
higher percent proliferation by Days 2 and 3 compared to the corresponding gel 
conditions without the addition of PTH (Table 4-3).  
 
 
 
 
 
 
Day 1 – RGD/no PTH Day 1 – RGD + PTH Day 1 – Unmodified + PTH 
Day 2 – RGD/no PTH Day 2 – RGD + PTH Day 2 – Unmodified/no PTH 
Day 3 – RGD/no PTH Day 3 – Unmodified/no PTH Day 3 – Unmodified + PTH 
Fig. 4-3. Representative images of nuclear (blue) and EdU (green) staining of chondrocytes 
cultured in unmodified alginate gels without PTH (Unmodified/no PTH), unmodified gels 
with 1 µM PTH (Unmodified + PTH), RGD-alginate gels without PTH (RGD/no PTH), and 
RGD-alginate gels with 1 µM PTH (RGD + PTH). No considerable differences in percent 
proliferation (i.e. percent EdU positive) were observed. 
 RGD
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4.3.2. Transcript expression levels  
On Day 1 of culture, expression of ColX (Fig. 4-4A) was statistically greater 
(p<0.05) in chondrocytes encapsulated in RGD-alginate compared to chondrocytes 
encapsulated in unmodified alginate, when no PTH was added to either condition; 
however, no differences existed between these two gel conditions when PTH was added. 
After two days in culture, ColX expression was significantly greater (p<0.05) in 
chondrocytes encapsulated in the unmodified alginate gels compared to those cultured in 
RGD-alginate, when no PTH was added to either gel condition. However, no difference 
was observed between the Unmodified + PTH and RGD + PTH conditions on Day 2. For 
both gel conditions, PTH treatment resulted in significantly reduced (p<0.05) expression 
of ColX in encapsulated chondrocytes by Day 2 compared to the corresponding gel 
conditions without PTH treatment. On Day 3 of culture, chondrocytes in the 
Day Sample EdU,Positive Cell,Count %,EdU,Positive
Day$1 RGD/no$PTH 92 2114 4.35%
Day$1 RGD$+$PTH 29 2793 1.04%
Day$1 Unmodified/no$PTH > > >
Day$1 Unmodified$+$PTH 81 2539 3.19%
Day$2 RGD/no$PTH 61 4003 1.52%
Day$2 RGD$+$PTH 42 2080 2.02%
Day$2 Unmodified/no$PTH 7 588 1.19%
Day$2 Unmodified$+$PTH > > >
Day$3 RGD/no$PTH 58 2848 2.04%
Day$3 RGD$+$PTH > > >
Day$3 Unmodified/no$PTH 33 3988 0.83%
Day$3 Unmodified$+$PTH 16 1315 1.22%
Table 4-3. Proliferation results of chondrocytes cultured in unmodified or RGD-
alginate gels, with or without PTH added to the culture media. Percent 
proliferation, i.e. %EdU positive, is based on the ratio of cells that stained positive 
for EdU to total number of cells (determined by nuclear Hoechst staining). Dashes 
represent sections that were lost during the staining process. 
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Unmodified/no PTH group still exhibited the greatest expression of ColX (p<0.05) 
compared to the RGD-alginate conditions. Furthermore, expression of ColX was 
significantly lower (p<0.05) in chondrocytes cultured in RGD-gels treated with PTH, 
compared to those in RGD-gels without the addition of PTH. Results for the Unmodified 
+ PTH treatment group were undetermined for Day 3.  
Likewise, expression of Ihh (Fig. 4-4B) on Day 1 of culture was significantly 
greater (p<0.05) in the RGD-alginate treatment group compared to the unmodified 
alginate treatment group, when no PTH was added to either condition. PTH treatment led 
to significantly lower Ihh expression in chondrocytes cultured in RGD-alginate gels, 
while no difference was observed between the Unmodified/no PTH and Unmodified + 
PTH groups. On Day 2 of culture, Ihh expression was significantly highest (p<0.05) in 
the Unmodified/no PTH treatment group. Furthermore, PTH-treated groups of both 
unmodified and RGD-alginate gels exhibited significantly lower (p<0.05) expression of 
Ihh compared to the corresponding gel condition without PTH. Although expression 
levels were significantly different between unmodified alginate and RGD-alginate 
conditions when no PTH was added, no difference was observed between the two gel 
conditions when PTH was incorporated into the culture media. On the third day of 
culture, no differences in Ihh expression existed between the unmodified alginate and 
RGD-alginate gel conditions, with or without the addition of PTH. However, Ihh 
expression was significantly reduced (p<0.05) in both gel conditions treated with PTH 
throughout the culture period.  
	   85 
 
On Day 1 and Day 2 of culture, no statistical differences in Sox9 expression (Fig. 
4-4C) existed between treatment groups. On Day 3, however, Sox9 expression in 
chondrocytes cultured in the RGD + PTH condition was significantly greater (p<0.05) 
than those cultured in the unmodified alginate conditions, with and without the addition 
Fig. 4-4. Expression levels of A. collagen X (ColX), B. Indian hedgehog (Ihh), and C. Sox9 
(Sox9) mRNA from chondrocytes cultured in unmodified alginate gels (Unmodified), 
unmodified gels with 1 µM PTH (Unmodified + PTH), RGD-alginate gels (RGD), and RGD-
alginate gels with 1 µM PTH (RGD + PTH). Means ± standard deviation values are expressed 
as a relative quality (RQ). RQs with different superscripts within each day for each transcript 
are significantly different (P < 0.05).  ColX results for the unmodified alginate/1µM PTH 
condition were undetermined for Day 3. 
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of PTH. When no PTH was added to either gel condition, no statistical differences were 
observed between the unmodified alginate and RGD-alginate groups. Furthermore, PTH 
addition did not significantly effect Sox9 expression on Day 3 in either the unmodified or 
RGD-alginate gel conditions. 
 
4.4. Discussion 
In the present study, unmodified and RGD-conjugated alginate hydrogel gels 
were used as an artificial 3-D matrix for growth plate chondrocyte culture over the course 
of 3 days, with and without the exogenous addition of soluble PTH. Previous studies have 
employed unmodified alginate gels for the in vitro culture of growth plate chondrocytes 
to evaluate the effects of 3-D culture on the expression of differentiation markers [92], as 
well as the effects of gelation conditions on chondrocyte formation in vitro [12], 
demonstrating that alginate gels are able to maintain chondrocyte genotype and 
phenotype in vitro compared to monolayer culture. Furthermore, RGD-conjugated 
alginate gels, in particular, have previously been investigated in several studies for their 
effects on chondrocyte behavior and chondrogenesis, including in vivo articular cartilage 
growth [24], in vitro chondrogenesis of bone marrow stromal cells [138], and calcium 
signaling response of articular chondrocytes to fluid flow [139]. However, the present 
study is the first to use an in vitro alginate model to test the effects of RGD ligands and 
soluble PTH on the behavior and gene expression of encapsulated growth plate 
chondrocytes.  
 The alginate encapsulation method utilized in this study was able to maintain 
chondrocyte viability throughout three days of culture, as demonstrated by live/dead 
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staining of a representative bead on each day. Furthermore, cell viability appeared to be 
unaffected by extra time spent in alginate solution prior to crosslinking, which can be 
concluded from the live/dead staining images of the first and last beads that were 
prepared from the alginate/cell suspension for the RGD/no PTH condition. These results 
confirm alginate’s gentle encapsulation process and its favorable use as a 3-D artificial 
matrix. No clear trends in cell proliferation could be concluded from EdU staining of the 
chondrocytes, despite some small differences between groups. Although the RGD peptide 
ligands did increase percent proliferation by Day 3 compared to the corresponding 
unmodified alginate condition, a larger proliferative effect was expected due to the 
peptide’s known ability to increase proliferation in other cell types cultured in RGD-
alginate gels [14, 27, 140]. These results, however, could be explained by the RGD 
ligand density chosen for this study (4 µmol/g), which may have been too low to induce 
substantial proliferation effects in the growth plate chondrocytes cultured in our system. 
Similarly, PTH treatment did not have a substantial effect on chondrocyte proliferation, 
although it did promote a slightly higher percentage of proliferating chondrocytes by 
Days 2 and 3 of culture. Unlike the results for RGD effect on proliferation, these PTH 
results were not surprising; the results of the present study support previous reports that 
revealed that Ihh is the driving force of proliferation in the growth plate and is 
independent of PTHrP signaling [141]; that is, changes in PTHrP-related parameters 
interact specifically with hypertrophy, as opposed to affecting rate of proliferation [86, 
142].  
In growth plate cartilage in vivo, PTHrP binds to its PTH/PTHrP receptor 
expressed by proliferating chondrocytes and suppresses chondrocyte hypertrophy, 
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retaining the chondrocytes in the proliferative zone [83, 85]. In areas where PTHrP 
concentration drops below a critical level, chondrocytes stop proliferating, begin 
hypertrophy, and start to produce Ihh and type X collagen [84]. Hence, PTHrP, and 
therefore PTH, acts to delay chondrocyte hypertrophy. According to the results of the 
present study, our alginate system was able to mimic this occurrence in vitro by Day 2 
and Day 3 of culture, which was indicated by the significantly lower expression of both 
ColX and Ihh as a result of PTH addition to chondrocytes cultured in unmodified and 
RGD-alginate gels. The Day 1 results, which did not follow this trend, can most likely be 
explained by the chondrocytes recovering from the dissection and encapsulation process 
and adjusting to the in vitro environment during this time; hence, 24 hours was not a long 
enough time for real changes in maturation state to occur. The fact that proliferation rates 
were not affected by PTH treatment despite greater Ihh expression in encapsulated 
chondrocytes that were not treated with PTH suggests that Ihh production, enabled by a 
lack of PTH, did not yet have time to stimulate chondrocyte proliferation by Day 3. 
Longer culture times could be evaluated in future studies to reveal this effect.  
Interestingly, RGD conjugation to alginate also suppressed the expression of 
hypertrophic markers in our in vitro system by days 2 and 3 compared to unmodified 
alginate gels. However, the addition of PTH to the culture media of unmodified and 
RGD-conjugated alginate gels eliminated the differences in hypertrophic gene expression 
that existed between the two gel conditions without the PTH treatment; therefore, PTH 
treatment, at the 1 µM concentration we used, overrides the hypertrophic effect of 
unmodified alginate on encapsulated chondrocytes when comparing to the same 
treatment in the RGD-alginate condition. The suppression of hypertrophy by RGD 
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peptide conjugation to alginate supports results from previous studies that investigated 
the effect of RGD ligands on chondrogenic differentiation in vitro [143, 144]. In a 
previous study involving the culture of growth plate chondrocytes seeded on fibronectin, 
an ECM protein that contains the RGD peptide as its active site, exogenously added RGD 
to the media resulted in increased alkaline phosphatase levels, implying terminal 
differentiation [143]. The terminal differentiation could be explained by the act of the 
exogenously added RGD blocking the link between cellular integrins and the RGD-
containing fibronectin protein, suggesting that interactions of chondrocytes with RGD 
ligands suppress terminal differentiation [143]. This effect was also demonstrated in the 
current study utilizing RGD-conjugated alginate; that is, higher ColX and Ihh expression 
levels in the unmodified gel condition compared to the RGD-conjugated gel condition 
indicated that hypertrophic effects were increased in the absence of RGD ligands. 
 Finally, Sox9 is a known transcription factor that acts at every stage of 
chondrocyte differentiation in the growth plate, from the formation of condensations by 
mesenchymal cells to the transformation of proliferating chondrocytes into hypertrophic 
chondrocytes [83, 145]. As Sox9 is essential for chondrocyte formation, Sox9 expression 
is often used as a marker for chondrocyte differentiation in in vitro studies to detect or 
confirm chondrogenic lineage. In the present study, Sox9 expression levels were 
evaluated to ensure that chondrocytes from each treatment group were not 
dedifferentiating during culture with respect to the other treatment groups. Overall, Sox9 
expression was similar in all treatment groups on each day, confirming that differences in 
Ihh and ColX expression levels between groups were not a result of dedifferentiation 
effects. 
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 In conclusion, this report reveals that PTH treatment and RGD peptide ligands 
suppress hypertrophy after Day 1 in chondrocytes cultured in alginate hydrogels, 
demonstrating the ability of these factors to regulate growth plate chondrocyte behavior 
within our 3-D culture system. This study was the first step utilizing this alginate culture 
model to evaluate factors necessary for inducing native growth plate architecture and 
function in vitro. Future studies with our 3-D in vitro culture system can focus on the 
effects of treatment with other signaling factors, such as Ihh, and the combination of 
signaling factors to produce feedback loops as seen in vivo. Furthermore, dose-dependent 
effects of PTH and other factors, along with variations in RGD ligand density and gel 
mechanics, can be investigated with our alginate culture system to identify optimal 
conditions for in vitro chondrocyte culture. Knowledge of the effects of these factors can 
be used to establish zonal arrangement of growth plate chondrocytes in vitro through the 
use of signaling gradients, which would have a significant impact on tissue engineering 
strategies for the replacement of growth plate cartilage damaged due to injury or disease.  
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CHAPTER 5 
 
Future studies and conclusions 
5.1. Introduction 
In this thesis, alginate hydrogel was first designed and characterized for its use as 
a 3-D matrix for in vitro models of tissue development. After demonstrating its ability to 
be manipulated in shape, chemical structure, and mechanical properties, alginate gels 
were employed as an artificial extracellular matrix (ECM) for pre-implantation pig 
embryo culture in vitro. This study validated the potential of the alginate culture system 
to serve as a matrix for an in vitro model of pig embryo development, in particular 
elongation during the pre-implantation stage of pregnancy. Next, unmodified and 
GRGDSP-conjugated alginate gels were used for the encapsulation and culture of mouse 
growth plate chondrocytes. This culture system was used as a model to study the effects 
of parathyroid hormone (PTH) and GRGDSP peptide conjugation on chondrocyte 
behavior, demonstrating that both PTH and RGD adhesion ligands decrease expression of 
collagen X and Indian hedgehog (Ihh) transcripts, two markers for hypertrophic 
chondrocytes, relative to control treatments. Together, the results presented in this thesis 
indicate alginate’s promising use as a 3-D matrix for in vitro models of pig embryo 
development as well as growth plate development. Future studies are needed to further 
investigate factors and mechanisms involved in development of these tissues, utilizing 
our alginate hydrogel system as the in vitro research tool. Recommended studies for both 
projects are described in detail below. 
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5.2. Future directions for the in vitro pig embryo model 
In Chapter 3, an in vitro culture system was established using a 3-D alginate 
hydrogel matrix that can support native embryo architecture and facilitate morphological 
changes of porcine embryos at the onset of elongation, in base serum media without the 
addition of special growth factors [50]. Furthermore, this system was shown to induce a 
corresponding increase in estrogen production and steroidogenic transcript expression, 
consistent with in vivo elongation [50]. With a base system established, the in vitro 
alginate culture system can now be used as a model for evaluating the effect of specific 
and undefined uterine factors on pre-implantation embryo development. Therefore, future 
studies involving the alginate culture model for pig embryo elongation should investigate 
the molecular and cellular aspects of pre-implantation embryo development in response 
to components added to the culture media or alginate gel that are known to exist in the 
uterus during elongation. The following three-tiered approach is recommended: 1) 
evaluate the effect of culturing encapsulated embryos within uterine flushes collected 
between days 9 through 12 of gestation; 2) evaluate the effect of specific uterine factors 
added to basal media or incorporated within the alginate on the development of 
encapsulated embryos; and 3) investigate the effect of co-culturing the encapsulated 
embryos with uterine lumen and glandular epithelial cells. Each of these approaches is 
described in detail below.  
The uterine environment prepares for embryo elongation and implantation by 
releasing nutrients, metabolites, and hormones in a time-dependent manner relative to 
paracrine signals from the embryo (i.e., estrogen) and endocrine/paracrine signals within 
the endometrium (i.e., progesterone) [69, 70, 146]. It has been shown that total protein 
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increases in the uterine lumen from day 7 to 10 in both cyclic and pregnant gilts followed 
by a more significant increase from day 10 to 13 [147]. Therefore, an evaluation of 
uterine milieu between days 9 through 12 of gestation should be made by adding uterine 
flushes from these pregnancies to basal culture media to determine the effect of 
undefined uterine components on embryo development within our alginate culture 
system. Preliminary studies were conducted to investigate whether uterine flushes from 
day 9 or day 10 of gestation were capable of supporting in vitro embryo development of 
in vivo-derived day 9 porcine embryos using the 3-D alginate culture system. Embryos 
collected on day 9 of gestation were assigned to be cultured in pooled day 9 flushes, day 
10 flushes, or base serum media for 96 hours within 0.7% alginate gels. Our 
morphological results revealed that encapsulated embryos cultured in base serum media 
(as used for the system in Chapter 3) exhibited the greatest percentage of morphological 
changes (22.22%) compared to the encapsulated embryos cultured in the day 9 (12.5%) 
or day 10 flushes (16.67%), as shown in Table 5-1. Furthermore, the trend was similar 
when comparing the percentage of surviving embryos with morphological changes across 
the media treatment groups (Table 5-1). 
In addition to observing embryonic survival and morphological changes, real-time 
PCR was used to analyze steroidogenic transcript expression at 96 h in the encapsulated 
embryos cultured in the uterine flushes compared to those cultured in base serum media. 
Overall, expression of steroidogenic transcripts STAR, CYP11A1 and CYP19A1 was 
greater in encapsulated embryos cultured in base serum media (Enc serum) compared to 
embryos cultured in the pooled day 9 (Enc d9) or day 10 flushes (Enc d10) (Fig. 5-1).  
Expression of STAR, CYP11A1 and CYP19A1 are known to be increased in a similar 
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pattern as estrogen production during embryo elongation [130, 131]; therefore, greater 
expression of these transcripts in the Enc serum group correlates with the higher 
percentage of morphological changes that occurred compared to the Enc d9 and Enc d10 
groups. 
 
 
Treatment D 9 D 9 Cont D 10 D 10 Cont Serum Serum Cont
57.14% 0.00%
3 0 4 0 4 0
33.33% 66.67% 41.67% 66.67% 38.89% 50.00%
22.22% 0.00%
24 6 24 6 18 10
8 4
Morph change from all 
embryos (%)
Morph change from 
surviving embryos (%)
12.50% 0.00% 16.67% 0.00%
37.50% 0.00% 40.00% 0.00%
Total no. of embryos
Embryo survival (n)
Embryo survival (%)
Morph change (n)
10 4 7 5
Table 5-1. Summary of embryo survival and morphological changes observed following 
96 h culture of day 9 porcine embryos encapsulated in 0.7% alginate gels. Encapsulated 
embryos were assigned to be cultured in day 9 uterine flushes (D 9), day 10 uterine flushes 
(D 10), or in base serum media (Serum).   
Fig. 5-1. Expression levels of CYP11A1 (blue), CYP19A1 (red), and STAR (green) 
mRNA measured by qPCR from Enc d 9 (encapsulated embryos cultured in d9 
flushes), Enc d 10 (encapsulated embryos cultured in d10 flushes) and Enc serum 
(encapsulated embryos cultured in serum media). Data were log-transformed 
before analysis and back-transformed to observable values.  Least-squares means 
± SEM values are expressed as a relative quality (RQ). 
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These preliminary results indicate that soluble factors present in uterine flushes at 
day 9 or day 10 of gestation do not support in vitro embryo development for 96 hours 
within our 3-D alginate culture system as efficiently as base serum media. These results 
are likely due to asynchrony issues between the embryos and their corresponding 
environment, which has previously been suggested to be one of the causes of early 
embryonic loss during the elongation stage of embryo development [148]. For example, 
an early increase in estrogen in the uterine environment of pregnant pigs (demonstrated 
by in utero injections 20-30 hours prior to elongation) stimulated a pre-mature increase of 
uterine secretions, resulting in increased embryo loss that was most likely due to the 
asynchrony of the embryos with the uterine environment [148]. Therefore, to overcome 
this issue, future studies with uterine flushes should involve a sequential uterine flush 
media system (i.e. sequential culture in day 9 through day 12 uterine flushes) to achieve 
appropriate synchrony between the embryo and the corresponding environment, thus 
establishing the most effective system to mimic in vivo elongation. Mass spectrometry 
can then be used to determine the specific proteins and growth factors within the pools of 
uterine flushes to determine differential concentrations of each factor in the flushes from 
days 9 through 12 of gestation, in order to correlate these factors to embryo development.  
In addition to undefined factors in uterine flushes, specific components up-
regulated within the uterine milieu during early pregnancy (e.g., TGFBs, FGF7, and 
OPN) should also be evaluated to explore biological pathways regulated during the pre-
implantation stage of embryo development. Adding these components to a basal media or 
within the alginate gels can be used to identify specific regulatory pathways that drive 
embryo elongation prior to implantation. Osteopontin (OPN), in particular, is an ECM 
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glycoprotein secreted by uterine epithelial cells that plays a role in the porcine 
implantation cascade during pregnancy [71]. OPN production by uterine epithelial cells is 
induced by estrogens secreted by the embryo during elongation and has been reported to 
stimulate cell-cell adhesion, increase cell-ECM interactions, and promote cell migration 
[149, 150]. Previous evidence suggests that the arginine-glycine-aspartic acid (RGD) 
peptide of OPN binds to integrin ανβ6 on the embryonic trophectoderm, inducing 
cytoplasmic reorganization during embryo elongation by stimulating cell-cell adhesion 
and promoting cell migration [151]. In previous in vitro studies, OPN has been shown to 
enhance development of early porcine embryos to the blastocyst stage when added 
exogenously to culture media [72]. Furthermore, Erikson and colleagues demonstrated 
that OPN stimulates migration of porcine trophectoderm cells via haptotaxis, supporting 
the hypothesis that OPN mediates cell migration during elongation [151]. Their results 
also indicated that the RGD sequence of OPN is required to stimulate haptotaxis of the 
trophectoderm cells, as no migration was observed with the OPN that contained a 
mutated binding sequence [151]. Given the potential involvement of OPN and other 
uterine factors during early embryonic development in the pig, further investigations are 
warranted to elicit the exact mechanisms by which these factors regulate pig embryo 
elongation. The alginate hydrogel system described in Chapter 3 was able to facilitate 
embryonic growth without any adhesion between the embryo and the matrix; this in vitro 
system can now serve as a “blank slate” for evaluating these mechanisms by 
incorporating factors that promote cellular adhesion and migration. 
 Preliminary studies have been performed to evaluate the effect of OPN and, more 
specifically, an RGD peptide sequence on embryo elongation within the in vitro alginate 
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hydrogel system. Day 9 pig embryos were encapsulated in one of the following treatment 
groups, using the same method as described in Chapter 3: unmodified alginate gels (Alg), 
alginate gels incorporating 0.1 µg/mL OPN (Alg + OPN), or alginate gels conjugated 
with GRGDSP peptide (RGD-Alg; prepared as described in Chapter 2). Non-
encapsulated embryos were used as a control group (Control). Results from these studies 
indicated that RGD-Alg promoted the greatest percentage of embryo survival (~68%) 
compared to the Alg and Alg + OPN treatment groups (Table 5-2). Furthermore, RGD-
Alg induced the greatest percentage of embryo morphological changes from all embryos 
(~43%) and from surviving embryos (~63%). The Alg + OPN treatment promoted 
intermediate percentages of embryo morphological changes from all embryos (~31%) 
and from surviving embryos (~62%). Representative images of embryos from each 
treatment group are pictured in Fig. 5-2. These results suggest the necessary role of OPN, 
and more specifically its RGD peptide, for proper embryo elongation. Additional studies 
are warranted for investigating a dose-effect of OPN and various RGD ligand densities 
on embryo development, along with the evaluation of triggered signaling pathways, to 
determine optimal levels for embryo elongation and mechanisms by which elongation is 
promoted by these factors.  
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Many of the factors within the uterine milieu that are described above are secreted 
by maternal epithelial cells via embryo-maternal signaling [68]. Because embryo-
maternal communication is vital for proper embryo development during the pre-
implantation stage of pregnancy, future studies should involve the co-culture of uterine 
lumen and glandular epithelial cells with the encapsulated embryos to determine if this 
embryo-maternal cross-talk can be mimicked in our alginate hydrogel system. The co-
Treatment Alg Alg + OPN RGD-Alg Control
Morph change from 
surviving embryos (%)
37.50% 62.50% 63.64% 0.00%
Morph change from all 
embryos (%)
18.75% 31.25% 43.75% 0.00%
Morph change (n) 3 5 7 0
Embryo survival (%) 50.00% 50.00% 68.75% 37.50%
Embryo survival (n) 8 8 11 6
Total no. of embryos 16 16 16 16
Table 5-2. Summary of embryo survival and morphological changes observed 
following 96 h culture of day 9 porcine embryos encapsulated in unmodified 
alginate (Alg), alginate blended with 1 µg/mL osteopontin (OPN), alginate 
conjugated with GRGDSP, and non-encapsulated control embryos (Control).   
0 hr 
Alg RGD-Alg Alg + OPN Control 
96 hr 
Fig. 5-2. Representative images of Alg, RGD-Alg, and Alg + OPN embryos that 
changed morphologically by 96 hours of culture, along with a control embryo 
that did not change morphologically, other than swelling. 
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culture model could lead to better understanding of specific embryo-uterine interactions 
during the elongation process. For co-culture studies, reproductive tracts can be collected 
from pregnant gilts to isolate uterine epithelial cells. Luminal and glandular epithelial 
cells can then be isolated and prepared for culture following a previously reported 
procedure [152]. After establishing a monolayer of these cells in culture, two different 
approaches are recommended for co-culturing the uterine cells with encapsulated pre-
implantation pig embryos. First, the uterine cells can be mixed in with the alginate prior 
to encapsulation, resulting in a cell-embedded gel surrounding the embryo (Fig. 5-3A). 
With this approach, the uterine epithelial cells would be surrounding the embryo in all 
directions, allowing for a more direct exposure to secretory factors. The second 
recommended approach involves culturing the alginate-encapsulated embryo on a 
monolayer of uterine epithelial cells (Fig. 5-3B). This approach would better mimic the 
uterine lumen environment, but would prevent direct contact between the embryo and 
uterine cells. Therefore, future studies employing both of these approaches would be 
attractive for establishing and evaluating maternal-embryo crosstalk in our in vitro 
alginate culture system. Overall, studies involving undefined uterine flushes, defined 
uterine components, and co-culture studies can be used together to identify and explore 
biological pathways regulated during the pre-implantation stage of pig embryo 
development. 
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Once uterine factors are evaluated and optimized to promote proper embryo 
elongation in vitro, the alginate culture system can be used to investigate biomechanical 
effects on elongation by culturing cells in various concentrations of alginate hydrogels, 
i.e. gels varying in stiffness (as demonstrated by mechanical testing in Chapter 2). 
Previous studies have found evidence that stiffness is important during embryogenesis in 
vivo. For example, during gastrulation in xenopus laevis, stiffening of the involuting 
marginal zone occurs to prevent the embryonic tissue from collapsing [153]. However, it 
remains unclear whether these changes in tissue stiffness occur solely for the purpose of 
providing mechanical stability or also occur in order to regulate other cellular processes 
via mechanotransduction [96]. Due to the complicated task of evaluating mechanical 
forces in vivo, an in vitro embryo model is necessary for understanding complex 
developmental behaviors that are regulated by mechanical forces. Preliminary studies 
involving the culture of day 9 pig embryos in 0.375%, 0.7%, and 1.5% alginate gels in 
base serum media demonstrated that 0.7% alginate promoted the greatest extent of 
embryonic morphological changes (data not shown); however, because mechanical 
Fig. 5-3. Schematic illustration of the approaches for co-culturing uterine cells with 
encapsulated pig embryos. A) Uterine epithelial cells can be mixed in with the alginate 
solution prior to encapsulation, resulting in the cells surrounding the embryo in all directions. 
B) Encapsulated embryo can be cultured on a monolayer of uterine epithelial cells. 
Uterine 
epithelial cell 
monolayer 
Embryo Embryo 
Uterine 
epithelial cells 
A B 
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properties may play a role in biochemical signaling, future studies should revisit the 
investigation of alginate biomechanics on embryo development in conjunction with 
optimal uterine factors and/or co-cultures. Furthermore, future studies with this model 
could investigate the effect of a mechanical gradient on embryo elongation, in which 
outer gel layers are composed of increasing concentrations of alginate. This approach 
would allow for the embryo to reside in a more permissive environment until it elongates 
and reaches the stiffer outer layers, which may help to prevent the embryo from extruding 
from the gel. The cylindrical and tubular alginate gels as well as the alginate wells 
described in Chapter 2 could also be used to investigate the effect of alginate 
biomechanics on embryo development; these methods would provide a greater amount of 
space for the embryo to elongate compared to the bead method, which resulted in 
embryos growing out of the gel by the end of culture in the studies described in Chapter 
3. Utilizing each of the aforementioned methods to investigate the influence of matrix 
biomechanics on pig embryo elongation could lead to the understanding of mechanical 
stability that may be required for proper elongation to occur.  
In addition to using our alginate system for studying molecular, cellular, and 
mechanical factors that promote elongation, as described above, future studies should 
encompass a more extended evaluation of embryo development in order to better 
correlate the in vitro results to in vivo occurrences. Unlike elongation in other domestic 
animals, rapid elongation of the pig embryo has been primarily associated with cellular 
remodeling and differentiation rather than cellular hyperplasia [61]. As a result, potential 
markers for differentiation of the trophectoderm (i.e., cytokeratin-18 [KRT18]) and 
mesoderm (i.e., vimentin [VIM]) have been identified in the elongating pig blastocyst 
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[62-64]. Therefore, future studies should assess cellular differentiation and proliferation 
in embryos that undergo a morphological change within the alginate hydrogels to 
determine if the growth is occurring via differentiation. One recommended method is to 
measure the expression of KRT18 and VIM transcripts in the encapsulated embryos and 
compare the expression levels to those of in vivo control embryos. Another recommended 
method involves a measure for the proliferation status of a cell population. Cellular 
proliferation can be quantified by determining mitotic index, i.e. the ratio of cells 
undergoing mitosis (condensed DNA) to the total number of visible cells. To calculate 
this ratio, nuclei in the embryos can be stained with DAPI and imaged with confocal 
microscopy. Cells in which the chromosomes are visible instead of an intact nucleus can 
be counted as undergoing mitosis. Preliminary staining of nuclei and actin on a day 9 in 
vivo-derived embryo was performed as a test, and representative confocal images are 
shown in Fig. 5-4 (white arrows indicate cells undergoing mitosis). Future investigations 
of mitotic index of embryos cultured in the alginate hydrogel system will determine if our 
encapsulated embryos change morphologically via similar mechanisms as in vivo 
elongating embryos, which will aid in demonstrating alginate’s ability to serve as a 3-D 
matrix for a developmental model of embryo elongation.   
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5.3. Future directions for the in vitro growth plate model 
In Chapter 4, 3-D alginate hydrogels were used as an in vitro extracellular matrix 
for growth plate chondrocytes to investigate the effect of RGD peptide ligands as well as 
exogenously added parathyroid hormone (PTH) on chondrocyte behavior in vitro. With 
this alginate culture system, we were able to determine that alginate conjugated with an 
RGD peptide suppressed chondrocyte hypertrophy compared to unmodified alginate, 
demonstrating the effect of this extracellular matrix adhesion peptide on chondrocyte 
behavior in vitro. Furthermore, the addition of PTH to the culture media of both RGD-
alginate and unmodified alginate cultures also repressed hypertrophy, as concluded by the 
lower expression of collagen X and Ihh transcripts in cells cultured with PTH compared 
to those cultured without PTH; these results demonstrated that the effect of PTH on 
chondrocyte hypertrophy in the growth plate can be mimicked to an extent within our in 
Fig. 5-4. Confocal microscopy images of in vivo-derived Day 9 embryo with actin and 
nuclei stained with phalloidin and DAPI, respectively. A) 10x magnification, scale bar = 
500 µm; B) 60x magnification, scale bar = 50 µm. Mitotic figures are denoted with white 
arrows in the 60x magnification image. 
A B 
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vitro alginate culture system. This study was the first step in using the alginate culture 
model to evaluate factors necessary for inducing native growth plate architecture and 
function for potential tissue engineering applications. The recommended next step is to 
evaluate PTH effect in a dose-dependent manner by varying PTH concentration. Future 
studies are then warranted for the investigation of signaling feedback loops, signaling 
gradients, mechanical gradients, and co-culture studies on in vitro chondrocyte behavior, 
utilizing alginate as the 3-D culture matrix. Recommended studies are described in detail 
below.  
Together, the interactions of parathyroid hormone-related protein (PTHrP) and 
Indian hedgehog (Ihh), a member of the hedgehog family of secreted ligands, form a 
feedback loop that regulates the length of the proliferative columns in growth plate 
cartilage and defines individual zones of chondrocyte maturation [83-85]. Studying 
factors independently and observing their isolated effects can lead to greater insight into 
the performance of a system as a whole. Therefore, in addition to observing PTH effects 
on chondrocyte behavior in vitro as described in Chapter 4, it is recommended that Indian 
hedgehog (Ihh) also be investigated independently for its effects on the in vitro behavior 
of growth plate chondrocytes. Sonic hedgehog (Shh) binds to the same receptors as Ihh, 
leading to activation of the same signaling pathways; hence, Shh can be used to represent 
the effects of Ihh. A preliminary study was conducted to observe the effects of 0.2 ng/mL 
and 0.5 ng/mL Shh on neonatal mouse growth plate chondrocytes encapsulated within 
GRGDSP-conjugated alginate gels. RT-PCR was performed to determine gene 
expression of transcripts involved in growth plate development and function. Expression 
levels of collagen X (Fig. 5-5A) and PTHrP (Fig. 5-5B) are reported here as an example 
	  105 
of transcript expression results obtained from this study. A dose-dependent effect of Shh 
was difficult to determine from the gene expression results of this preliminary study, 
suggesting that the concentrations of Shh used (0.2 ng/mL and 0.5 ng/mL) were too low 
for our model. Due to hindered diffusion to the cells through the alginate gel, 
recommended concentrations for future Shh experiments should be an order of magnitude 
higher to observe clear effects.   
 
Once PTH and Shh are evaluated independently in the alginate model, their 
cooperative effects should then be evaluated by delivering both PTH and Shh to alginate-
encapsulated growth plate chondrocytes during the same experiment. Dose-dependent 
effects should be tested again for these cooperative studies as the optimal concentrations 
of each factor may change when added to culture media together.   
Another variable that should be tested in future studies is the incorporation of 
PTH and/or Shh into the alginate solution prior to crosslinking, in contrast to adding the 
factors to the culture media after beads are crosslinked, as was done in the study 
described above and in Chapter 4. This approach would be advantageous for maintaining 
A B 
Fig. 5-5. Expression levels of A. Collagen X and B. PTHrP measured by RT-PCR from 
chondrocytes encapsulated in RGD-alginate and cultured with, 0 ng/mL, 0.2 ng/mL, or 0.5 
ng/mLsonic hedgehog (Shh). Means ± SEM values are expressed as a relative quantity (RQ). 
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an efficient localized concentration of signaling factors around the cellular environment 
throughout the duration of culture. Preliminary release studies demonstrated alginate’s 
ability to retain PTH within the beads for a duration of 5 days, with very little release 
during this time (data not shown). If longer release studies show that a more sustained 
release is needed for longer culture times, recommended studies should investigate the 
incorporation of heparin into the alginate beads; the heparin should bind to the signaling 
factors and aid in preventing release. Another option to promote sustained release (and 
therefore inhibit burst release) from alginate hydrogels would be to chemically modify 
alginate with sulfate groups. Sulfation of alginate mimics heparin’s affinity for certain 
growth factors, including PTH and Ihh/Shh, and has previously been used to provide 
protection and sustained release of heparin-binding growth factors [42]. However, 
published methods for sulfation of alginate involve the use of harsh solvents, specifically 
the reaction of alginate with chlorosulfuric acid in formamide [39]. Future studies 
involving the investigation of signaling factors within the alginate model should explore 
the possibility of a safer, non-toxic method to achieve alginate sulfation.  In vivo, Ihh 
diffusion from hypertrophic cells to perichondral cells is regulated by Ihh binding to 
heparan sulfate in the extracellular matrix [86]. Therefore, the incorporation of heparin or 
conjugation of sulfate groups would allow the alginate system to better mimic the in vivo 
extracellular matrix of the growth plate.  
 In addition to investigating the effects of soluble factors added to our chondrocyte 
culture system, RGD ligand density should be varied and studied for its effect on 
chondrocyte behavior. The methods described in Chapter 4 involved the conjugation of 
GRGDSP peptide to alginate at only one concentration, and this particular concentration 
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(estimated to be approximately 4 µmol/g alginate [14]) significantly decreased the 
expression of collagen X in encapsulated chondrocytes compared to unmodified alginate, 
suggesting a decrease in the amount of hypertrophic cells. Varying the concentration of 
GRGDSP on the alginate backbone will vary the amount of cellular adhesion sites, and 
may therefore further affect proliferation and/or hypertrophy of encapsulated 
chondrocytes [27]. Peptide conjugation, however, occurs on the carboxylic acid groups of 
the alginate polymer backbone, which are the same groups that participate in ionic 
crosslinking with calcium for hydrogel formation [39]. As a result, increasing ligand 
density may decrease the stiffness of resulting gels. Young’s moduli of gels with various 
RGD peptide densities should therefore be tested to determine if mechanics differ 
significantly with increased ligand density.  
Finally, mechanical and chemical gradients should be established with these 
alginate hydrogels and investigated for their effects on in vitro growth plate chondrocyte 
behavior. The cylindrical gel method (Fig. 5-6A and 5-6B) or layered bead method (Fig. 
5-6C and 5-6D), both described in Chapter 2, can be used to establish these gradients. 
With the cylindrical gel method, chondrocytes can be encapsulated within the middle 
area of the cylinder to represent the proliferative zone. Ihh can then be incorporated at a 
high concentration at one end of the cylinder, representing the hypertrophic zone of Ihh-
expressing chondrocytes, with decreasing concentrations towards the other end of the 
cylinder. At the opposite end, PTH can be incorporated at high concentrations, 
representing the resting zone, with decreasing concentrations towards the Ihh-
concentrated end. This method is depicted in Fig. 5-6A. A co-culture study involving 
transfected HEK293T cells that express Ihh or PTH could also be used to establish 
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signaling gradients in place of the factors themselves (Fig. 5-6B). The layered bead 
method uses a similar approach in that chondrocytes can be encapsulated in a middle 
layer, with PTH and Ihh or PTH- and Ihh-expressing cells incorporated into the inner and 
outer gel layers (Fig. 5-6C and 5-6D). Preliminary studies involving the encapsulation of 
rat chondrosarcoma (RCS) cells with Ihh-expressing HEK293T cells within alginate 
beads demonstrated that RCS cells were successfully encapsulated within an outer gel 
layer surrounding an inner bead of HEK293T cells (Fig. 5-7).  
 
 
Cells 
expressing 
Ihh 
A.# B.# Chondrocytes 
Cells expressing 
Ihh 
Cells expressing 
PTH 
Ihh 
Chondrocytes 
PTH 
Chondrocytes 
D.#
Chondrocytes 
Ihh C.#
PTH Cells 
expressing 
PTH 
Fig. 5-6. Schematic illustration of the encapsulation of chondrocytes and formation of 
chemical gradients within alginate hydrogels via incorporated signaling factors (A,C) or 
co-culture with factor-expressing cells (B,D). Gradients can be established in a cylindrical 
gel formation (A,B) or with a layered bead method (C,D).  
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For both the cylindrical gel method and layered bead method, different 
concentrations of alginate can be used in each layer to establish a gradient of mechanical 
properties to determine biomechanical effects on growth plate chondrocyte behavior. A 
recent approach to the manipulation of transcription factors that have been discovered to 
play important roles in cartilage and bone formation is to consider the mechanical 
influences on their regulation [84]. For example, studies have revealed that 
biomechanical stimuli influence the regulation of NF-κβ transcription factors, which 
generate intracellular signals that induce or suppress pro-inflammatory and reparative 
genes in chondrocytes [154, 155]. Furthermore, a study involving chitosan substrates of 
varying stiffness properties revealed that increased stiffness promoted articular 
chondrocyte growth and proliferation [156], linking the biomechanical environment to 
cartilage development and function. Therefore, future studies involving mechanical 
gradients within our in vitro growth plate model could reveal biomechanical mechanisms 
Fig. 5.7. 1.5% RGD-alginate bead with two gel layers, consisting of Ihh-
expressing HEK293T cells (HEK) encapsulated within the inner bead and 
rat chondrosarcoma cells (RCS) encapsulated within the outer layer. Cells 
were live/dead stained prior to imaging with a fluorescence microscope. 
RCS 
HEK 
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that underlie spatial organization of chondrocytes in the growth plate. Taken together, the 
optimal combination of appropriate biomechanics, ECM factors, and signaling gradients 
are hypothesized to generate native cartilage architecture in vitro, in particular a distinct 
zone of proliferating columnar chondrocytes as seen in vivo.  
 
5.4. Conclusions 
This thesis describes the establishment of in vitro culture systems for pre-
implantation pig embryos and growth plate chondrocytes via a tissue engineering 
approach, utilizing alginate hydrogels as a 3-D scaffold. Alginate, a linear polysaccharide 
derived from brown algae, demonstrated tunable physical and chemical properties, 
making it an ideal matrix for in vitro culture models. In regards to pig embryo culture, 
embryos encapsulated within alginate hydrogels exhibited greater survival and 
morphological change than non-encapsulated control embryos, along with increased 
expression of steroidogenic transcripts and estrogen production, consistent with in vivo-
elongation. However, this system consisted of only a base serum media; therefore, future 
studies should use this alginate hydrogel system as a tool for evaluating specific uterine 
and/or biomechanical factors that play a role in embryo elongation, with further endpoint 
evaluations to characterize elongation. These factors can then be targeted to improve 
pregnancy outcomes, thereby increasing sow productivity and the profitability of swine 
production. In addition, alginate hydrogels were used for the encapsulation of growth 
plate chondrocytes in vitro to study the effects of soluble PTH, a signaling factor that 
regulates growth plate structure and function, along with the effects of an RGD peptide 
conjugated to alginate. This study demonstrated that both PTH and RGD peptide ligands 
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play a role in the regulation of chondrocyte hypertrophy in our in vitro alginate system 
with similar effects as seen in vivo, as indicated by the decrease in collagen X and Ihh 
transcript expression. However, this study was only the first step in the evaluation of 
factors that effect growth plate chondrocyte behavior to determine necessary factors for 
inducing native growth plate architecture in vitro. Future studies using this alginate 
system should involve the investigation of dose-dependent effects of signaling factors 
and RGD peptide ligands, as well as mechanical and/or chemical gradients on 
chondrocyte structure and function.  Knowledge of microenvironmental parameters that 
induce cartilage architecture can then be used in tissue engineering strategies to 
regenerate native cartilage to address critical health issues associated with growth plate 
injury and disease. Overall, information gained from utilizing these in vitro models as 
research tools can be used to advance the field of developmental biology and enhance 
tissue engineering therapies for the treatment of degenerative diseases.  
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